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Prosthetic heart valve (PHV) dysfunction is rare but potentially life-threatening. Although often challenging, establishing the exact cause of PHV
dysfunction is essential to determine the appropriate treatment strategy. In clinical practice, a comprehensive approach that integrates several
parameters of valve morphology and function assessed with 2D/3D transthoracic and transoesophageal echocardiography is a key to appro-
priately detect and quantitate PHV dysfunction. Cinefluoroscopy, multidetector computed tomography, cardiac magnetic resonance imaging,
and to a lesser extent, nuclear imaging are complementary tools for the diagnosis and management of PHV complications. The present docu-
ment provides recommendations for the use of multimodality imaging in the assessment of PHVs.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Keywords echocardiography † cardiac magnetic resonance † cinefluoroscopy † computed tomography † nuclear imaging †
prosthetic heart valve
* Corresponding author. Tel: +32 4 366 71 94; Fax: +32 4 366 71 95. E-mail: plancellotti@chu.ulg.ac.be
† Endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging.
EACVI Documents Reviewers: Nuno Cardim (Portugal), Erwan Donal (France), Maurizio Galderisi (Italy), Kristina H. Haugaa (Norway), Philipp A. Kaufmann (Switzerland), Denisa Muraru (Italy).
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2016. For permissions please email: journals.permissions@oup.com.
European Heart Journal – Cardiovascular Imaging
doi:10.1093/ehjci/jew025
 European Heart Journal - Cardiovascular Imaging Advance Access published May 3, 2016







Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Types of PHVs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Echocardiographic assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2D echocardiographic examination . . . . . . . . . . . . . . . . . . . . . . 4
Doppler echocardiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Colour Doppler echocardiography . . . . . . . . . . . . . . . . . . . . . . 6
3D echocardiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Stress echocardiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Additional imaging modalities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Cinefluoroscopy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Cardiac computed tomography . . . . . . . . . . . . . . . . . . . . . . . . . 8
Cardiovascular magnetic resonance . . . . . . . . . . . . . . . . . . . . . . 8
Nuclear cardiology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
PHV function and characteristics . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Morphologic and functional characteristics . . . . . . . . . . . . . . . . 9
Leaflet motion and occluder mobility . . . . . . . . . . . . . . . . . 9
Acoustic shadowing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Microbubbles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Spontaneous echo contrast . . . . . . . . . . . . . . . . . . . . . . . . 11
Strands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Haemodynamic characteristics . . . . . . . . . . . . . . . . . . . . . . . . . 12
Flow patterns (anterograde flows) and clicks . . . . . . . . . . 12
Pressure gradients and EOA. . . . . . . . . . . . . . . . . . . . . . . . 14
Transprosthetic flow velocity and gradients . . . . . . . . 14
Effective orifice area . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Doppler velocity index . . . . . . . . . . . . . . . . . . . . . . . . . 15
Parameters of flow ejection dynamics . . . . . . . . . . . . . 15
Pressure recovery and localized high gradient . . . . . . . . . 17
Physiologic regurgitation (retrograde flows) . . . . . . . . . . . 17
PHV dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Structural valve dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Non-structural valve dysfunction . . . . . . . . . . . . . . . . . . . . . . . 18
Pathologic PHV regurgitation . . . . . . . . . . . . . . . . . . . . . . . 19
Imaging evaluation of PHV dysfunction . . . . . . . . . . . . . . . 20
Patient-prosthesis mismatch . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Follow-up and monitoring. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Valve-specific approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Aortic prosthetic valve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Baseline assessment and serial reports. . . . . . . . . . . . . . . . 24
Imaging assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Valve morphology and function . . . . . . . . . . . . . . . . . . . . . 25
Acquired aortic PHV obstruction . . . . . . . . . . . . . . . . . . . . 25
Doppler assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Integrative assessment. . . . . . . . . . . . . . . . . . . . . . . . . . 26
Differential diagnosis of high-pressure gradients. . . . . 28
Pathological aortic regurgitation . . . . . . . . . . . . . . . . . . . . . 28
Colour Doppler evaluation . . . . . . . . . . . . . . . . . . . . . 28
Integrative assessment. . . . . . . . . . . . . . . . . . . . . . . . . . 30
Mitral prosthetic valve. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Baseline assessment and serial reports . . . . . . . . . . . . . . . 31
Imaging assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Valve morphology and function . . . . . . . . . . . . . . . . . . . . . 32
Acquired mitral PHV obstruction. . . . . . . . . . . . . . . . . . . . 33
Doppler assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Integrative assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Differential diagnosis of high-pressure gradients. . . . . . 34
Pathological mitral regurgitation . . . . . . . . . . . . . . . . . . . . . 35
Colour Doppler evaluation. . . . . . . . . . . . . . . . . . . . . . . 35
Integrative assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Tricuspid prosthetic valve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Baseline assessment and serial reports. . . . . . . . . . . . . . . . 38
Imaging assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Valve morphology and function . . . . . . . . . . . . . . . . . . . . . 38
Acquired tricuspid PHV obstruction . . . . . . . . . . . . . . . . . 39
Doppler assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
Integrative assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . 39
Differential diagnosis of high-pressure gradients. . . . . . 40
Pathological tricuspid regurgitation. . . . . . . . . . . . . . . . . . . 40
Colour Doppler evaluation. . . . . . . . . . . . . . . . . . . . . . . 40
Integrative assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Pulmonary prosthetic valve . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Baseline assessment and serial reports . . . . . . . . . . . . . 40
Imaging assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Valve morphology and function . . . . . . . . . . . . . . . . . . . . . 42
Acquired pulmonary PHV obstruction . . . . . . . . . . . . . . . . 42
Doppler assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Integrative assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Pathological pulmonary regurgitation . . . . . . . . . . . . . . . . . 43
Colour Doppler evaluation. . . . . . . . . . . . . . . . . . . . . . . 43
Integrative assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . 43
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Introduction
Valvular heart disease affects .100 million people worldwide and
represents a growing problem because of the increasing burden
of degenerative valve disease in the ageing population and of the still
high incidence of rheumatic heart disease in developing countries.1
About 4 million prosthetic heart valve (PHV) replacements have
been performed over the past 50 years, and this remains the only
definitive treatment for most patients with severe valvular heart dis-
ease.2 The total number of replacements is projected to be 850 000
per year by 2050.3
PHV dysfunction is rare but potentially life-threatening. Although
often challenging, establishing the exact cause of PHV dysfunction is
essential to determine the appropriate treatment strategy.4,5 In clinical
practice, a comprehensive approach that integrates several para-
meters of valve morphology and function assessed with 2D/3D trans-
thoracic (TTE) and transoesophageal (TOE) echocardiography is a key
to appropriately detect and quantitate PHV dysfunction. Cinefluoro-
scopy, multidetector computed tomography (CT), cardiac magnetic
resonance imaging (CMR), and to a lesser extent, nuclear imaging
are complementary tools for the diagnosis and management of PHV
complications.4,5 The present document provides recommendations
for the use of multimodality imaging in the assessment of PHVs.
Types of PHVs
A number of valve designs have been withdrawn or are currently im-
planted only rarely. However, these may still require imaging either
as routine or on the suspicion of malfunction. Replacement valves
are broadly grouped as biological or mechanical (Table 1).6,7
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The most frequently implanted biological valve is a stented bio-
prosthesis. These are composed of fabric-covered polymer or
wire stents with a sewing ring outside and the valve inside. The valve
may be a whole porcine valve (Table 2) (e.g. Carpentier-Edwards
standard or Hancock standard). However, there is a muscle bar at
the base of the porcine right coronary cusp, which can make it rela-
tively obstructive. This cusp may therefore be excised and replaced
by a single cusp from another pig (e.g. Hancock Modified Orifice), or
more frequently, each cusp may be taken from three different pigs to
produce a tricomposite valve (e.g. Medtronic Mosaic, St Jude Epic or
Carbomedics Synergy). Stented pericardial bioprostheses have
cusps made from pericardium (Table 2) or a sheet of pericardium
cut using a template and sewn inside the stent posts or occasionally
to the outside of the stent posts (e.g. Mitroflow, Trifecta). Usually
the pericardium is bovine, but occasionally porcine and, experimen-
tally, from kangaroos. The bioprostheses also differ in the method of
preservation of the valve cusps, the use of anticalcification regimes,
and the composition and design of the stents and sewing ring.
Stentless bioprosthetic valves usually consist of a preparation of
porcine aorta. The aorta may be relatively long (e.g., Medtronic
Freestyle) or may be sculpted to fit under the coronary arteries
(e.g., St Jude Medical Toronto). Some are tricomposite (e.g.
Cryolife-O’Brien, Biocor) or made from bovine pericardium (e.g.
Sorin Freedom) (Table 2). Homograft valves consist of human aortic
or occasionally pulmonary valves, which are usually cryopreserved.
They have good durability if harvested early after death and do not
need anticoagulation. For this reason, they may be used as an alter-
native to a mechanical valve in the young. They may also be used for
choice in the presence of endocarditis since they allow wide clear-
ance of infection with replacement of the aortic root and valve and
the possibility of using the attached flap of donor mitral leaflet to re-
pair perforations in the base of the recipient’s anterior mitral leaflet.
The stentless valves were introduced to increase the orifice area
available for flow. It was also hoped that stresses on the cusps might
be lessened leading to better durability and that some stent-related
complications such as valve thrombosis might be less frequent.
The Ross Procedure consists of substituting the patient’s diseased
aortic valve by his own pulmonary valve.8 Usually a homograft is
then implanted in the pulmonary position. It is an infrequently per-
formed operation requiring extensive training. It is justified because
a living valve is placed in the systemic side allowing good durability. It
is therefore an alternative in younger patients who do not wish to
take regular anticoagulation. The autograft may grow which makes
it particularly appropriate for children to reduce the need for repeat
operations during growth. It is likely to resist infection better than
valves, which include non-biological material and may also be used
for preference in patients with infective endocarditis.
Sutureless valves (Table 2) were developed in the hope of redu-
cing bypass times in patients at high risk from conventional surgery
and to facilitate a minimally invasive approach.9
Transcatheter valves are a relatively new technology for patients
at high risk for conventional valve replacement or in whom thora-
cotomy is not feasible or appropriate for technical reasons: e.g. por-
celain aorta or when there is a left internal mammary graft crossing
the midline.10 These are the subjects of separate guidelines.11
The most frequently implanted mechanical valves are now the bi-
leaflet mechanical valves (Table 3). The various designs differ in the
composition and purity of the pyrolytic carbon, in the shape and open-
ing angle of the leaflets, the design of the pivots, the size and shape of
the housing, and the design of the sewing ring. For example, the St Jude
Medical valve has a deep housing with pivots contained on flanges,
which may sometimes obscure the leaflets on echocardiography, while
the Carbomedics standard valve has a shorter housing allowing the
leaflet tips to be imaged more clearly. Single tilting disk valves and oc-
casionally the Starr-Edwards caged-ball valve are also used.
Table 2 Designs and models of biological replacement
heart valve
Stented porcine replacement valve
† Hancock standard and Hancock II
† Medtronic Mosaica
† Carpentier-Edwards standard and
supra-annular









† Carpentier Edwards Magna
† Mitroflow Synergy
† St Jude Biocor pericardia
† St Jude Trifecta
† Labcor pericardial
† Sorin Pericarbon MOREa
Stentless valve Porcine
† St Jude Medical Torontoa
† Medtronic Freestyle
† Cryolife-O’Briena
† Cryolife-Ross Stentless porcine
pulmonary
† Edwards Prima Plus
† AorTech Aspire
† St Jude Biocor
† Labcor
† St Jude Quattro stentless mitral
† Shelhigh Skeletorized









† Perceval S (Sorin)
† Edwards Intuity (Edwards
Lifesciences)
† 3F Enable (ATS Medical)
† Trilogy (Arbor Surgical
Technologies)
aIndicates withdrawn from market.
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These valve types differ, mainly for the aortic site, by implantation
position relative to the annulus. Valves are intra-annular, partially
supra-annular or entirely supra-annular. The partially supra-annular
valves have a supra-annular sewing ring, but part of the housing within
the annulus (e.g. On-X, St Jude HP). Wholly supra-annular valves have
all parts of their mechanism above the annulus in the aortic site (e.g.
Carbomedics ‘Top Hat’, Medtronic Mosaic) and occasionally in the
mitral position (e.g. Carbomedics Optiform). The supra-annular pos-
ition is designed to lift as much of the replacement valve above the
annulus to maximize the orifice area available for flow. The maximum
label size implantable may then be limited by the diameter of the aor-
tic root or the position of the ostium of the right coronary artery.
Comparison of the different valve types is difficult because of major
variations in sizing convention.12 This means that for a given patient
tissue annulus, there may be major differences in the label size. In a
study13 comparing valve label size against a modelled tissue annulus
provided by machined polypropylene blocks, the ‘tissue annulus’
diameter ranged from 3.5 mm smaller to 3.0 mm larger than the
labelled size.
Echocardiographic assessment
2D and Doppler echocardiography are essential for initial and lon-
gitudinal assessment of patients with PHV.14 Although such evalu-
ation follows the same principles as for native heart valves, the
echocardiographic examination of PHV is more challenging. At
the time of echocardiography, it is essential to know and document
(i) the reason for the echo study; (ii) the patient’s symptoms; (iii) the
type and size of the PHV; (iv) the date of surgery; (v) the blood pres-
sure and heart rate; and (vi) the patient’s height, weight, and body
surface area (Table 4). A comprehensive echocardiographic study
is indicated in case of new murmur or any symptoms possibly re-
lated to PHV. When obtained early after hospital discharge, it can
serve to define baseline PHV characteristics (‘fingerprint’).
2D echocardiographic examination
2D TTE is recommended as first-line imaging in PHV.7,14 A 2D TOE
is more likely to be needed for the evaluation of PHV structure and
associated complications.15 It is advocated in all cases of PHV
dysfunction.16,17
The complete echocardiographic imaging of the PHV includes the
use of multiple views (conventional parasternal and apical TTE views
or mid-oesophageal 2-3-4-chamber, commissural, and transgastric
TOE views and off-axis views) with attention to determine the
type of prosthesis, confirm the adequate valve leaflet/occluder
morphology and mobility, check the integrity and stability of the
sewing ring (any rocking motion), identify the presence of calcifica-
tion or abnormal structures on any of the various components of
the PHV, assess the size of cardiac chambers, the LV wall thickness
and mass, the indices of LV systolic and diastolic function, and the
systolic pulmonary arterial pressure (SPAP). Additional findings
such as the aortic root and ascending aorta should be evaluated in
case of aortic PHV (Table 5).
Magnification of real-time 2D images is often necessary for opti-
mal visualization. M-mode enables better evaluation of valve move-
ments (assessment of the brisk opening and closing and the degree
Table 3 Designs and models of mechanical
replacement heart valve
Bileaflet mechanical replacement valves
† St Jude Medical: standard, HP, Masters,
and Regent
† Carbomedics: standard, reduced cuff,
Optiform, Orbis, and supra-annular





















aIndicates withdrawn from market.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 4 Essential parameters in the comprehensive
evaluation of prosthetic valve function
Parameters
Clinical information † Date of valve replacement
† Type and size of the prosthetic valve
† Height, weight, body surface area,
and body mass index
† Symptoms and related clinical
findings
† Blood pressure and heart rate
Imaging of the valves † Motion of cusps, leaflets, or
occluder
† Presence of calcification or
abnormal structures on the various
components of the prosthesis




† Spectral Doppler envelope
† Peak velocity and gradient
† Mean pressure gradient
† Doppler signal velocity time integral
(VTI)
† Doppler velocity index (DVI)
† Pressure half time in mitral and
tricuspid valve
† Effective orifice area (EOA)
† Presence, location, and severity of
regurgitation
Other imaging data † LV and RV size, function, and
hypertrophy
† LA and RA size
† Co-existent valvular disease




† Comparison of above parameters in
suspected prosthetic valvular
dysfunction
EOA, effective orifice area; LA, left atrial; LV, left ventricle; RA, right atrial.
Adapted from Zoghbi et al.14
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of excursion of the occluder) and corresponding time intervals and
recognition of quick movements. Prosthetic disc motion is better
evaluated in the mitral position since opening and closing angles
can be identified in 77 and 100% of patients by TTE and TOE, re-
spectively.18 On the contrary, in the aortic position, the opening an-
gles (not closing angles) of single disc prostheses are identified in
only 40 and 77% of patients by TTE and TOE, respectively, and
for bileaflet mechanical prostheses in 13 and 35%, respectively.18
Since intermittent cyclic or non-cyclic dysfunction of mechanical
prostheses can occur (intermittent increase in transprosthetic gra-
dients), careful examination of the gradients and disc motion during
several consecutive beats is recommended.
Doppler echocardiography
The principles of flow assessment through PHVs are similar to those
used in evaluating native valve, including interrogation from multiple
windows and proper alignment of the Doppler beam with flow dir-
ection.19 – 21 Doppler recordings should be performed at a sweep
speed of 100 mm/s. Measurements should be taken over one to
three cycles in sinus rhythm. In atrial fibrillation, Doppler measure-
ments should be performed during periods of physiologic heart rate
(65–85 bpm), whenever possible; an average of five cycles is recom-
mended. For calculations of valve effective orifice area (EOA) and
Doppler velocity index (DVI), which require measurements from
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 5 Imaging modalities: advantages and limitations
Technical considerations Advantages Limitations
2D TTE † Multiple views
† Careful probe angulation (alignment)
for accurate leaflet motion display
† First-line imaging
† Ease of use
† Assessment of LV function and size
and pulmonary pressure
† Limited by acoustic window and body
habitus
† Acoustic shadowing by prosthetic
material
† Angle dependent on accuracy of
Doppler data
2D TOE † Multiple views
† Careful probe angulation (alignment)
for accurate leaflet motion display
† Higher resolution than TTE
† Proximity of the oesophagus with the
heart
† Better visualization of the atrial side
of mitral PHV and posterior part of
aortic PHV
† Better visualization of peri-annular
complications
† Acoustic shadowing by prosthetic
material
† Angle dependent on accuracy of
Doppler data
3D TOE † Multiple cropping planes
† Narrow angle mode/Oblique views
† Full-volume dataset
† Zoom mode
† Ease of use
† Excellent spatial imaging
† Enable enface viewing (surgical view)
† Add on to 2D echo imaging
† Poor visualization of anterior cardiac
structure
† Poor temporal resolution
† Tissue dropout
† Lack of tissue characterization
† Artefacts due to an oblique (rather
than horizontal) orientation of PHVs in
mitral position
Cinefluoroscopy † Postero-anterior (08) and lateral (908)
projections
† ‘in profile’ projection (beam parallel to both the
valve ring plane and the tilting axis of discs)
† ‘en face’ projection (beam parallel to the valve
outflow tract)
† Ease of use
† Evaluation of PHV functioning
† Detection of calcium on the leaflets
† No haemodynamic assessment
† No clues about the aetiology of limited
disc motion
Cardiac CT † Wider exposure windows and multiphasic
reconstructions for assessment of valve
mobility
† Double oblique planes (short- and long-axis
views)
† 3D data set
† Not limited by body habitus
† Good for aortic pathology
† High sensitivity for detection of
calcification
† Allows visualization/differentiation
of thrombus and pannus
† Excellent spatial imaging
† Radiation exposure
† Potentially nephrotoxic contrast
† Contrast allergies
† Artefacts from metallic objects
CMR † T1-weighted spin echo and gradient echo
sequences (steady-state free-precession and
fast gradient echo)
† Phase-contrast sequences
† Good for aortic pathology (even
without contrast)
† No ionizing radiation
† Myocardial characterization
† Artefacts from metallic objects
† Limited data in prosthetic valves
† Limited spatial and temporal resolution
Nuclear imaging † Different tracers to image inflammation,
calcification, or metabolism
† Extent of local infectious/metabolic
activity
† Identify extracardiac infection/
metabolic activity
† Radiation exposure
† Limited data in prosthetic valves,
except in infective endocarditis
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different cardiac cycles, matching the respective cycles lengths to
10% is recommended.14 Doppler recordings should be obtained
in quiet respiration or in mid-expiratory apnoea. TTE is the method
of choice for Doppler signal recordings. However, when technically
difficult, TOE is indicated.
Colour Doppler echocardiography
Colour Doppler assessment should be performed in multiple win-
dows with appropriate colour Doppler settings (Nyquist limit
around 50–60 cm/s). Colour Doppler evaluation enables discrimin-
ating physiologic from pathologic flows and between intra- and/or
paraprosthetic regurgitation. The origin and direction of the jets
should be evaluated. Localization of paravalvular regurgitation may
be difficult and the use of multiple transthoracic transducer posi-
tions, including off-axis views, is recommended.20 In this regard,
TOE is often necessary, particularly in mitral and tricuspid valves
for which it is superior to TTE. TOE remains essential for assessing
paravalvular regurgitation.11,14,15 Regurgitant jets may be occulted
by acoustic shadowing.
3D echocardiography
Real-time 3D echocardiography, particularly during TOE, is suitable
for the evaluation of PHVs and provides incremental advantage over
2D imaging.22,23 The 3D ‘en-face’ surgical view of the valve is ex-
tremely helpful for determining PHV function and defining the pres-
ence, origin, direction, and extension of regurgitant jets.11,24 – 27
Leaks are defined by 3D echocardiography as echo dropout areas
outside the sewing ring confirmed by colour Doppler. 3D echocar-
diography allows advantageous visualization of PHV components
such as the leaflets, rings, and struts (leaflets or disc material sup-
port), irrespective of the position. The presence and localization
of thrombus formation, pannus, and prosthetic valve dehiscence
can be evaluated by 3D echocardiography.28 – 33 This is especially
useful for the assessment of mechanical mitral and aortic valves
where 2D images are often of poor quality due to acoustic shadow-
ing. With 3D imaging, the ventricular side of mitral prosthetic valves,
which is consistently prevented with 2D imaging, can be often
visualized.27
After locating the best plane for imaging the PHV by standard
2D images, narrow-angled acquisition mode, 3D zoom mode,
full-volume acquisition (single or multi-beat with ECG gating) with
and without colour Doppler can be performed. Once the
3D data sets are acquired, they can be cropped to optimally
visualize cardiac structures. By convention, the mitral valve image,
as viewed from the left atrial perspective, is rotated to position
the aortic valve at 12 and the left atrial appendage at 9 o’clock.11,26
A 5 o’clock is assigned to the commissure between the left and
right coronary sinuses, and 8 o’clock to the commissure between
the non-coronary and left coronary sinuses. Aortic paravalvular
leaks are more commonly located between the right and non-
coronary cusps.34
There are a few limitations to 3D imaging such as poor visualiza-
tion of anterior cardiac structures, poor temporal resolution, sub-
optimal images due to poor ECG triggering in patients with
arrhythmias, and tissue dropout. Traditionally, 3D zoom mode pro-
vides images of high spatial resolution at the expense of temporal
resolution with frame rates typically ,10 Hz. This may hamper
the ability to visualize fast moving structures such as vegetations
and the dynamic behaviour of mitral rings. Anterior cardiac struc-
tures such as the aortic and tricuspid leaflets due to their increased
distance from the TOE probe cannot be visualized as well as poster-
ior structures such as the posterior mitral valve leaflet.11,26
Stress echocardiography
Stress echocardiography is a valuable tool for the evaluation of
PHVs haemodynamic function, especially when there is discordance
between the patient’s symptomatic status and the PHVs haemo-
dynamics.4,5,11,35 In patients with no, mild, or equivocal symptoms,
the preferred modality is exercise stress echocardiography. Semi-
supine bicycle exercise test is technically easier than upright bicycle
or post-treadmill, especially when multiple stress parameters are as-
sessed at the peak level of exercise. A low dose (up to 20 mg/kg/
min) dobutamine stress echocardiography can be used in patients
with moderate or severe symptoms or when an exercise test is im-
possible. Details about stress echocardiography protocols are pro-
vided elsewhere.36,37
Key points
2D TTE is recommended as first-line imaging in PHV. TTE is also the method
of choice for Doppler signal recordings. Both TTE and TOE are needed for
complete evaluation in a patient with suspected PHV dysfunction. 3D
echocardiography, especially with TOE, can provide additional information
and is increasingly used. For both TTE and TOE, it is essential to obtain
images in multiple views and multiple planes to ensure complete
visualization of the valvular and paravalvular region. TTE/TOE has higher
sensitivity in mitral than aortic position for examining disc valve motion. For
the evaluation of PHV regurgitation, TOE is superior in mitral/tricuspid
position while TTE is better in aortic position. TOE, especially when




Fluoroscopy is an easy and readily available non-invasive technique for
evaluating mechanical PHVs. It is mainly indicated in case of abnormal-
ly high gradients. The method allows correct identification of the type
of implanted prosthesis and evaluation of its functioning.38 – 40
Through appropriate projections, valve leaflet mobility, valvular ring
motion, or even rupture and/or migration of parts of the valve can
be evaluated. Abnormal tilting or rocking of the base ring is indicative
of extensive valve dehiscence. This exam does not, however, allow
haemodynamic assessment or provide clues about the aetiology of
reduced disc mobility.
Generally, cinefluoroscopic study is carried out with the patient
in the supine position. PHVs are viewed in three main projections:
(i) the postero-anterior (08) and lateral (908) projections to identify
the ‘in situ’ orientation of the valve; (ii) the ‘in profile’ projection (with
the radiographic beam parallel to both the valve ring plane and the
tilting axis of discs), allowing calculation of opening and closing an-
gles and; (iii) the ‘en face’ projection (with the radiographic beam
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parallel to the valve outflow tract) which is utilized only for mitral
prostheses. For all views, due to variability in surgical prosthesis
orientation, careful patient positioning and the use of cranio-caudal
angulation are frequently required. Of note, cinefluoroscopy pro-
vides a better evaluation of the motion of discs in the aortic position
than echocardiography.41
A short (10 beats) cinefluoroscopic film in each projection is
acquired, from which frames are selected to evaluate and measure
the disc motion radius. The opening and closing angles are calcu-
lated as the distance between the two leaflets in the fully open
and closed positions (Figure 1A, Panel A and B). For single disc pros-
theses, the opening angle is defined as the distance between the
housing and the disc at its fully open position, and for bileaflet
disc prostheses as the distance between the leaflets in the fully
open position (Figure 1B). The method is usually feasible despite
poor radio-opacity of some mechanical valves.
Figure 1 (A) Evaluation of closing (Panels a and c) and opening angles (angle between discs in the fully open and closed positions) (Panels b
and d) of mechanical bileaflet valves as performed using cinefluoroscopy (Panels a and b) and cardiac computed tomography (Leaflet angles relative
to the plane of the orifice ring) (Panels c and d). (B) Evaluation of opening (Panel e) and closing angles (Panel f) of mechanical tilting disk valve as
performed using cinefluoroscopy.
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Of note, detection of calcium on the leaflets of a tissue valve is
diagnostic of degeneration but does not allow assessment of its
hemodynamic impact.
Cardiac computed tomography
Cardiac CT is generally not performed for routine evaluation, but
rather when valvular dysfunction or other complications are sus-
pected. It can provide incremental information on valvular mobility,
integrity, and (para) valvular pathology (e.g. endocarditis, aneurys-
mal dilatation, or other involvement of the surrounding tissues).42,43
CT can be used as an alternative to fluoroscopy for mechanical PHV
to measure the opening/closing angles (Figure 1A, Panel C and D) and
could be considered for imaging the cusps of biological valves (leaf-
let thickening, visualization of calcification, or thrombus) if TOE is
inconclusive.44 – 47 Malcoaptation may be visible, allowing in some
cases planimetric quantification of the regurgitant valve orifice. Para-
valvular regurgitation may be identified, depending on the size of the
defect and the radiopacity of the valve ring.48,49 Ring dehiscence may
be appreciated by a rocking displacement of the valve ring on dy-
namic CT reconstructions. CT can distinguish thrombus from pan-
nus.50 – 54 CT can be used to quantify the severity of stenosis in a
bioprosthesis by planimetry of the anatomic orifice area (geometric
orifice area, GOA).45 The morphological consequences of obstruct-
ive or regurgitant valve dysfunction can be observed in the form of
ventricular or atrial dilatation or stasis of contrast medium suggest-
ing congestion. In preparation for redo surgery, cardiac CT can also
be of use to assess the coronary status or the patency of bypass
grafts, particularly in younger patients with non-degenerative valvu-
lar heart disease.55,56 To avoid unintended trauma during sternot-
omy, CT can assess the space between the sternum and the right
ventricle. Impingement or injury of the left circumflex coronary ar-
tery, though rare, may occur because of its proximity to the annulus,
and can be assessed by CT angiography.57
Using ECG-synchronized acquisition or reconstruction of data
nearly motion-free images (depending on the temporal resolution)
with a sub-millimetre isotropic spatial resolution can be acquired
and reconstructed in any imaginary cross-sectional plane. If data
are acquired throughout the cardiac cycle, then images can be re-
constructed representing consecutive cardiac phases, which sub-
sequently allows for assessment of structural displacement.
Contrary to real-time echocardiography, dynamic CT reconstruc-
tions (repeatedly) display only a single heart cycle. Dynamic assess-
ment of radiopaque mechanical valves does not require injection
of contrast medium, similar to cinefluoroscopy. Similarly to coron-
ary CT angiography, pharmacological heart rate modulation may
be used.58 PHVs are visualized best in the fully open or closed po-
sitions. Nominal opening angles depend on the type of PHV and
sometimes also on its implanted location (Table 6).6,49 – 51,59
Contrast-enhanced imaging of right-sided valves, particularly the
tricuspid valve, is complicated by non-homogeneous opacification
when contrast arrives selectively from the superior cava vein. Ei-
ther the image is acquired during recirculation or contrast is in-
jected at an appropriate timing and proportion simultaneously
via an upper and lower limb vessel to improve contrast homogen-
eity in the right heart.
Disadvantages of cardiac CT are the use of iodine contrast me-
dium and the need for ionizing radiation. Depending on the type
of scanner, the selected scan protocol, and the requirement for
single- or multiphasic images, the radiation dose varies between
1 and 20 mSv.60 Cardiac CT is further limited by its inability to as-
sess flow and haemodynamics. Pledget material adjacent to the valve
ring may also be misinterpreted as regurgitation, although the dens-
ity is often slightly higher than the contrast-enhanced blood.61
Cardiovascular magnetic resonance
CMR has been demonstrated to be safe in patients with PHV, in
whom it is commonly used to assess concomitant aortic path-
ology.62 CMR is an excellent technique for volumetric assessment
of cardiac chambers and flows and may be of value for assessing
the function of the PHV itself, especially as a complementary meth-
od when TTE is non-diagnostic and TOE undesirable.63– 66 CMR can
thus be used for valve analysis using steady-state free precession
(SSFP) sequences, which precisely discriminate blood from tissue.67
Turbulent flow through a regurgitant orifice is easily visible with
SSFP (visualization of signal voids due to spin dephasing in moving
protons).63,64 PHV anatomy can be imaged by acquisition of stand-
ard short-axis, two-, three-, and four-chamber long-axis views in
combination with oblique long-axis cines orthogonal to the line of
coaptation.68 Leaflet motion restriction may be identified. GOA
may also be measured in bioprosthetic valves.69 No study has re-
ported on the evaluation of pannus or thrombus using CMR. In
some circumstances, assessing the anatomic regurgitant orifice
area by planimetry of the regurgitant orifice in a slice parallel to
the valvular plane and perpendicular to the regurgitant jet is feasible
using SSFP CMR.70 Furthermore, blood flow and velocity might also
be obtained by phase-contrast velocity mapping.71 –73 CMR is thus a
useful tool for assessing regurgitation, especially in the follow-up of
replacement pulmonary valves. Even though its value has been in-
creasingly proved for the quantitation of regurgitation in native
valves and to a lesser degree after transcatheter aortic valve im-
plantation, there are very limited data in patients with surgically im-
planted PHVs. CMR may also potentially demonstrate abnormal
asymmetrical flow patterns in PHV obstruction, although leaflet an-
gle measurements may not always be possible. Late gadolinium en-
hancement CMR (images obtained 10–20 min after injection of
contrast) is widely used to assess cardiac fibrosis in various cardio-
myopathies.74 In patients with PHVs, CMR might serve to evaluate
the impact of valve replacement on the myocardial structure. To
date, for the heart valves that have been tested, CMR-related heat-
ing has not been shown to reach substantial levels.75– 77 Moreover,
although CMR provides information on PHV-related flow patterns
and velocities, more studies are required to provide diagnostic ref-
erence values to allow discrimination of normal from pathological
conditions.
Nuclear cardiology
The use of nuclear imaging modalities in the assessment of PHVs is
limited. However, recent interest has surrounded the use of
18F-fluorodeoxyglucose positron emission tomography (PET) in
the detection of PHV endocarditis,78 which is not the scope
of the present document. Other recent studies suggest that
18F-sodium fluoride PET/CT is able to identify active tissue calcifi-
cation and predict disease progression in patients with native aortic
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stenosis.79 Further studies are needed to determine whether this
technique would be able to identify active mineralization of biopros-
thetic valve tissues and thereby predict the risk of structural valve
degeneration.
Key points
Non-echo imaging modalities are generally not performed for routine
evaluation of PHV, but rather when valvular dysfunction or other
complications are suspected. They can provide incremental information on
valvular integrity and valvular/paravalvular pathology. Cinefluoroscopy has
a complementary role in evaluating disc mobility of mechanical PHVs and
valve ring structure. Cardiac CT is also an important adjuvant imaging
technique that permits visualization of calcification and degenerative
changes of biological prosthesis, pannus formation, the presence of
thrombus, and assessment of movement of occluders in mechanical valves.
The use of CMR is not yet routine practice but is increasing. Nuclear
imaging currently has very limited application in the evaluation of PHV
other than in the setting of suspected infective endocarditis.
PHV function and characteristics
Morphologic and functional
characteristics
Leaflet motion and occluder mobility
Mechanical PHVs have specific patterns of echoes that can help
identify the type of prosthesis.7,14,80– 82 In normal PHVs, the motion
is brisk and consistent with each beat. Nominal opening angles
depend on the type of PHV and sometimes also on its location
(Table 6).39,40,49– 51,59
A ‘ball-caged mechanical valve’ displays a cage and the moving
echo of the ball on the ventricular side. In 2D echo, the metallic
struts provide highly reflective echoes. Conversely, the proximal
surface of the valve provides less intense echoes. In real time, the
poppet moves forward and backward in the cage. For a replacement
valve in the mitral position, the poppet is seated in the sewing ring in
systole. On M-mode, the cage, the sewing ring, and the ball provide
four distinct echoes.
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Starr-Edwards Three (aortic) or four-strut (mitral)
cobalt-chrome alloy cage
Silicone rubber N/A N/A
Tilting disc valves
Bjo¨rk–Shiley Cobalt-chrome alloy Silicon alloyed pyrolytic carbon on graphite









Omniscience Titanium alloy Silicon alloyed pyrolytic carbon on tungsten-loaded
graphite substrate
80 12
Omnicarbon Pyrolytic carbon over graphite substrate Silicon alloyed pyrolytic carbon on tungsten-loaded
graphite substrate
80 12
Sorin Allcarbon Cobalt-chromium alloy coated with a thin
layer of pyrolytic carbon




ATS Medical Pyrolytic carbon over graphite substrate
with metallic band
Silicon alloyed pyrolytic carbon on tungsten-loaded
graphite substrate
85 25
Carbomedics Solid pyrolytic carbon with titanium
stiffening ring metallic band






Solid pyrolytic carbon with titanium
stiffening ring
Silicon alloyed pyrolytic carbon on tungsten-loaded
graphite substrate
73–77 15
St Jude Medical Pyrolytic carbon over graphite substrate
with metallic band
Silicon alloyed pyrolytic carbon on tungsten-loaded
graphite substrate
85 30 (19–25 mm)
25 (27–31 mm)
On-X Pyrolytic carbon with graphite substrate
with titanium alloy bands
Pure pyrolytic carbon on tungsten-loaded graphite
substrate
85–90 40
Bicarbon Cobalt-chromium alloy coated with a thin
layer of pyrolytic carbon
Silicon alloyed pyrolytic carbon on tungsten-loaded
graphite substrate
80 20
Leaflet angles relative to the plane of the orifice ring as provided by the manufacturers. Note that the angles are measured using the same approach by cardiac computed
tomography. Conversely, on cinefluoroscopy, opening and closing angle in bileaflet PHVs are defined as the angle between discs in the fully open and closed positions, respectively.
This means that the opening angle is the angle between the two discs (generally ,308 and in the majority of valves ,208). The closing angle is usually .1208–1308.
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A single echo movement up and down on the ventricular side can
be seen with ‘tilting disc valve (monoleaflet)’. The opening angle of
the disc relative to the valve annulus ranges from 608 to 808 resulting
in two orifices of different size. On M-mode, the opening of the
valve forms an intense echo with multiple reverberations.
Two separate disks can be visualized in ‘bileaflet PHV’; they open
and close almost in synchrony. The opening angle of the leaflets rela-
tive to the annulus plane ranges from 758 to 908, with the open valve
consisting of three orifices: a smaller, slit-like central orifice between
the leaflets, and two larger semi-circular orifices laterally (Figure 2).
‘Biological valves’ have a trileaflet structure, which normally ap-
pears thin (1–2 mm) with unrestricted motion and no evidence
of prolapse.1,7,9,83 Their 2D and M-mode appearances reveal a box-
like opening in systole in the aortic position and in diastole in mitral
or tricuspid position, similar to that of native valves. The sewing ring
and the struts (the three struts are shown in the short-axis view in
Figure 3) are however more echogenic, which can limit the visualiza-
tion of the leaflets (Figure 3A and B). Stentless aortic bioprostheses
or aortic homografts have a similar appearance to that of native aor-
tic valves, except for an increased thickness in the LV outflow tract
and the ascending aorta. Early after implantation, a stentless valve in-
serted as an inclusion can be surrounded by haematoma and oe-
dema. Sutures are defined as linear, thick, bright, multiple, evenly
spaced, usually immobile echoes seen at the periphery of the sewing
ring of a PHV; they may be mobile when loose or unusually long.
The 3D appearance of biological valve, in any anatomical position,
is always similar with the appearance of a native aortic valve, with
three cusps, with a larger diameter when used in mitral or tricuspid
position and with a smaller diameter when used in aortic or
pulmonary position.
Acoustic shadowing
Prosthetic materials, particularly in mechanical models, cause
numerous ultrasound artefacts, including acoustic shadowing, rever-
berations, refraction, and mirror artefacts (Figure 4, Panel A–E).14,84
This often affects imaging quality and is even more pronounced in
case of double PHVs. Multiple and sometimes off-axis views must
be used to overcome these problems and interrogate areas around
the prostheses. At lower gain settings, the valves are generally better
visualized.
Generally, the left/right atrial (LA/RA) side of a prosthetic mitral/
tricuspid valve is obscured by acoustic shadowing from the TTE
approach, resulting in a low sensitivity for detection of prosthetic
mitral or tricuspid regurgitation (MR, TR), thrombus, pannus, or
vegetation (Figure 5, Panel A and B). TOE provides superior images
of the LA/RA side of the mitral/tricuspid prosthesis (Figure 5, Panel C
and D). In the aortic position, the posterior aspect of the valve ap-
pears shadowed on TTE (Figure 4, Panel A) while the anterior aspect
of the valve is shadowed on TOE (Figure 4, Panel C to E).85,86
For stented valves, the ultrasound beam should be carefully
aligned parallel to the flow to avoid shadowing effects of the stents
and sewing ring.87
Artefacts created by mechanical valves are different for cardiac
CT compared with echocardiography or CMR. Partial volume com-
bined with interpolation effects created during image reconstruc-
tion causes metal (-coated) structures to appear larger
(hyperdense artefact, blooming, and bright streak), while beam-
hardening effects create dark shadows (hypodense artefact). These
artefacts are most severe during phases of rapid displace-
ment.31,36,40 Valves with cobalt-chrome rings (Bjo¨rk–Shiley valve)
suffer most severe beam-hardening artefacts. Prospective ECG
Figure 2 Mechanical valve in mitral position: normal appearance. 2D and 3D transoesophageal echocardiographic (TOE) appearance of a normally
functioning mechanical valve in mitral position. (A–D) 2D and 3D as well as 2D and 3D colour flow appearance of a bileaflet mechanical valve in the
opened position from the atrial perspective. Note the two lateral semi-circular orifices and the central slit-like orifice both visible in 2D and 3D TOE.
Note the normal anterograde colour flow Doppler and the flow acceleration at the level of the three orifices in 2D TOE (B). (E–H) 2D and 3D as well
as 2D and 3D colour flow appearance of a bileaflet mechanical valve in the closed position from the atrial perspective. Note the normal appearance of
the retrograde colour flow Doppler showing physiologic ‘washing jets’ for this type of prosthesis in 2D (F) and 3D colour flow imaging (H ). The
volumetric reconstructed cardiac computed tomography scan of the bileaflet valve from the atrial (open, I) and ventricular (close, J ) perspective.
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triggering can reduce PHV-induced artefacts compared with retro-
spective ECG gating.
PHVs also produce artefacts with CMR signal loss relative to dis-
tortion of the magnetic field by the metal mechanical valves hold.75
Artefacts are less with biological valve. Artefacts are more pro-
nounced with gradient-echo cines and less on spin-echo images.65
Microbubbles
Microbubbles are characterized by a discontinuous stream of
rounded, strongly echogenic, fast-moving transient echoes.88 Micro-
bubbles occur at the LV inflow zone of the valve when flow velocity
and pressure suddenly drop at the time of prosthetic valve closing,
but may also be seen during valve opening. The cavitation potential
is likely correlated with valve design, occluding material, and the vel-
ocity of the leaflet closure.89 Microbubbles are common in the
mitral position (Figure 6, Panel A). They are probably due to carbon
dioxide degassing and linked to hypercoagulability of blood near the
valve though of doubtful significance. They might be at the origin of
high-intensity transient signals in the cerebral circulation, which can
be detected using transcranial Doppler examination of the middle
cerebral artery.90 They can be observed in both normal and dys-
functional mechanical PHVs. Microbubbles are not found in bio-
prosthetic valves.
Spontaneous echo contrast
Spontaneous echo contrast (SEC) is defined as smoke-like
echoes.84 The prevalence of SEC is 7 to 53%. SEC is caused by in-
creased red cell aggregation that occurs in slow flow (e.g. low car-
diac output, severe LA dilatation, atrial fibrillation, and pathologic
obstruction of a mitral prosthesis).
Strands
Strands are thin, mildly echogenic, filamentous structures that are several
millimetre long (often,1 mm thick and.2 mm up to 30 mm length)
and move independently from the PHV (Figure 6, Panel B).91–93 They
Figure 3 Bioprostheses: normal appearance. 2D and 3D transthoracic (TTE) and transoesophageal (TOE) echocardiography appearance of
bioprosthetic replacement valves. (A) 2D TTE appearance of a normal bioprosthesis in mitral position; the frame on which the leaflets are attached
is a strong echo-reflector leading to acoustic shadowing (white arrows). However, this phenomenon is of lesser magnitude than in mechanical
valves. The ventricular and atrial sides of one of the leaflets are nicely delineated (red arrows). (B) 2D TOE at 1208 appearance of a normal bio-
prosthesis in aortic position as seen in diastole: the frame of the valve is nicely seen leading to discrete acoustic shadowing; the aortic and ven-
tricular sides of two of the leaflets are clearly seen in the long-axis view. (C) 2D TOE at 458 appearance of a normal bioprosthesis in aortic position,
as seen in diastole, from the aortic side. The three pillars of the metallic frame on which the leaflets are mounted are seen at 1, 5, and 10 o’clock
(arrows), as well as the coaptation lines of the leaflets. (D) Same image as in C but from a 3D perspective. (E) The atrial aspect of a normal bio-
prosthetic valve in mitral position in diastole from a 3D perspective. The ring of the prosthesis as well as the atrial surface of the three leaflets in
systole are seen in detail
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are often visible intermittently during the cardiac cycle but recur at
the same site. They are usually located at the LV inflow side of the
PHV (i.e. the atrial side of a mitral prosthesis or the ventricular side
of an aortic prosthesis). They can be observed on both mechanical
and biological PHVs. Strands are found in 6 to 45% of patients.93 Pros-
thetic valve-associated strands are likely to have multiple causes; they
may have a fibrinous or a collagenous composition. Strands have been
found to be more common in patients undergoing TOE for evaluation
of the source of embolism than in patients examined for other rea-
sons.93 Although this association may imply an embolic potential, their
meanings and therapeutic implications remain unclear.
Key points
Mechanical PHVs have specific patterns of echoes that can help identify the
type of prosthesis. The echocardiographic assessment of PHVs can be limited
by the shadowing effect particularly for the mitral prosthesis from the TTE
approach and partially for the aortic prosthesis from the TOE views.
Haemodynamic characteristics
All normal functioning mechanical PHVs cause some degree of ob-
struction to blood flow, closure backflow (necessary to close the
valve), and leakage backflow (after valve closure).87,94
Flow patterns (anterograde flows) and clicks
Blood flow through normally functioning PHVs differs from flow
through native valves. The pattern of anterograde flow is unique
to each valve and depends on the shape and number of orifices
through which forward flows occurs.7,14,80 – 82,94 – 96 Double-
envelope spectral Doppler profiles may often be seen in mechan-
ical PHVs. Spectral Doppler recordings of PHV flow also include
brief, intense, high-velocity signals referred to as clicks due to
the opening and closing of the occluder mechanism (Figure 4F
and 5E). The colour map should entirely fill the orifice in all views
(Figure 2B).
In the setting of a ‘single disc’, the large major orifice (semi-
circular jet in cross-section) may create a dense and typically lower
velocity jet arising from the major orifice, and a faint (could be also
two or three jets depending on the number of struts), higher-
velocity jet from the minor orifice.
Similarly, ‘bileaflet mechanical valves’ generate a dense, lower vel-
ocity jet arising from the two lateral orifices, with a faint higher vel-
ocity jet arising from the central orifice. (Figure 2, Panel F ). Three
separate jets thus characterize the pattern of the anterograde trans-
valvular flow (Figure 2, Panel B).
With ‘caged-ball PHVs’, blood flows goes around the entire cir-
cumference of the ball and gives two curved side jets and a large
wake in the central part.
Figure 4 Mechanical valve in aortic position: normal appearance. Acoustic shadowing and reverberations seen with 2D transthoracic and trans-
oesophageal echocardiography when imaging a mechanical valve in aortic position depending on the acoustic view used (A–E, yellow arrows). (F )
Continuous wave Doppler (CWD) signal showing the opening and closing clicks (white arrows) of a normally functioning aortic valve, an early
peak velocity and a normal mean and peak pressure gradient across the prosthesis. (G) M-mode showing normal opening and closure of the discs.
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Figure 6 Mechanical valve in mitral position: cavitation and strands. (A) Cavitation (yellow arrow) inside the left ventricular cavity related to the
presence of a mechanical valve in mitral position, as seen from the apical transthoracic approach. (B) Fibrin strands (orange arrow) seen as fine
filamentous masses attached to the atrial side of a mechanical valve in mitral position as seen from the transoesophageal approach.
Figure 5 Mechanical valve in mitral position: normal appearance. Acoustic shadowing and reverberations seen with 2D transthoracic and trans-
oesophageal echocardiography when imaging a mechanical valve in mitral position depending on the acoustic view used (A and B, acoustic shadow-
ing and reverberations on the atrial side (LA) vs. C and D on the ventricular (LV) side. (F) Pulsed wave Doppler (PWD) signal showing the opening
and closing clicks (white arrows) of a normally functioning mitral valve. M-mode showing normal opening and closure of the discs.
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With ‘bioprosthesis’, a single central anterograde flow pattern is
observed.
Pressure gradients and EOA
The haemodynamic performance of most PHVs is inferior to that of
the normal native valve.7,12–14,96,97 Hence, PHVs often cause some
degree of obstruction to blood flow, which may vary depending on
the model and size of prosthesis as well as the patient’s body size.2,14
Quantitative parameters of PHV function include transprosthetic
flow velocity (highest velocity signal in PHVs) and pressure gradi-
ents, effective orifice area (EOA), and DVI (Tables 1 and 2).
Transprosthetic flow velocity and gradients
Doppler echocardiography takes advantage of the relationship de-
fined by the Bernoulli equation between velocity and pressure, to
assess gradients.98 Using the Bernoulli equation, the difference in
pressure across a restrictive orifice is defined as:
DP = P1− P2 = 4(V22 − V21 )
where P1 and V1 are the pressure and velocity, respectively, prox-
imal to the restrictive orifice; and P2 and V2 are the pressure and vel-
ocity, respectively, distal to the orifice. The peak difference between
pressures is the peak instantaneous gradient, and the average differ-
ence over the duration of flow is the mean gradient. Since V2 .. V1
and the vicious friction are ignored, the energy balance through the
orifice simplifies to:
DP = 4(V22 )
which is the simplified Bernoulli equation used to translate the vel-
ocity from echocardiography to a pressure drop. However, espe-
cially in normally functioning bioprostheses, V2 values may be low
(often ,2 m/s), so the use of the simplified Bernoulli equation (de-
fault setting on the echo machine) can cause significant overesti-
mation of pressure gradients.99 This overestimation may be
negligible in obstructive PHVs (often seen with mechanical valves)
with high V2 values (from +3 to +5%), but it may be clinically sig-
nificant in normally functioning biosprostheses (from +13 to
+19%).99 In these situations, estimation of the pressure gradient
is more accurately determined by integrating the velocity proximal
to the prosthesis into the Bernoulli equation (DP = 4(V22 − V21 )).
The peak velocity across the prosthesis is to some extent related
to valve size with the small prostheses having higher velocities,
but since velocities are determined by cardiac output and systemic
vascular resistance, there may be overlap between different valve
sizes of a particular type of prosthesis.7 In patients with aortic pros-
theses and high cardiac output or narrow LV outflow tract (LVOT),
the velocity proximal to the prosthesis may be elevated and there-
fore not negligible (proximal velocity .1.5 m/s).100,101
Because of the inherent risks related to crossing a prosthetic valve
with a catheter, invasive assessment of prosthetic valve haemo-
dynamics is rarely used. There is generally a good correlation be-
tween peak and mean pressure gradients determined invasively
and non-invasively.14,100 – 103 However, if significant pressure recov-
ery is present, such as in patients with a small aorta, the pressure gra-
dients measured by left heart catheterization are lower than those
measured by Doppler echocardiography. The peak-to-peak pres-
sure gradient measured by catheter is substantially lower than the
peak instantaneous gradient measured by catheter or Doppler. Gi-
ven that the aortic and LV pressure peaks do not occur at the same
time, the peak-to-peak pressure gradient has no physiological mean-
ing.19,95 Furthermore, it is highly influenced by aortic compliance.
Hence, this parameter should not be used for the assessment of na-
tive or prosthetic aortic valves. Underestimation of the gradients
can be observed in the presence of (i) failure to align the Doppler
beam parallel with the highest velocity jet (ideal angle ,208),
(ii) any low flow state (gradients are known to be sensitive to
flow), (iii) elevated systemic blood pressure. Overestimation of
the gradients can be observed in the presence of (i) any high flow
state, (ii) mistaking MR flow signal for transaortic flow signal (MR
starts earlier and lasts longer than aortic flow), (iii) angle correction
of Doppler interrogation relative to the direction of blood flow (this
is not recommended), (iv) the pressure recovery phenomenon
(Doppler gradient substantially higher than the invasively deter-
mined pressure gradient, particularly in patients with a small aorta).
Effective orifice area
The EOA is not the same parameter as the GOA (the internal valve
area theoretically available for the bloodstream to pass through).104
The EOA is always smaller and describes the functional area.105 The
EOA indeed corresponds to the smallest area of the jet passing
through the prosthesis as it exits the valve (vena contracta). Both
the shape of the inlet and the size of the orifice affect the ratio be-
tween GOA and EOA (coefficient of flow contraction). Clinically,
the coefficient of contraction varies from 0.90 to 0.71, which may
result in up to a 29% difference between the EOA and GOA.106
The theoretical GOA can be calculated from the internal orifice
diameter of the prosthesis stent provided by the valve manufac-
turers. In bioprosthetic valves, the GOA can be measured by plan-
imetry from echocardiographic, CT or CMR images.45,65 The
theoretical GOA grossly overestimates the planimetered GOA, be-
cause it assumes that the whole internal area of the prosthesis stent
is available for blood flow, which is not the case. The valve leaflets
indeed occupy a substantial proportion of the stent orifice. Further-
more, the planimetered GOA overestimates the EOA due to the
flow contraction phenomenon described above.45,65 It is important
to underline that, from a pathophysiologic standpoint, the transvalv-
ular pressure gradients are essentially determined by the EOA.107
Hence, the gradients correlate better with EOA than with GOA.
The prosthetic valve EOA is less flow dependent than the trans-
prosthetic velocity or gradient, and is thus often a better index of
intrinsic valve haemodynamic performance (Tables 1 and 2).19 How-
ever, this parameter is more prone to technical pitfalls and measure-
ment errors. For both aortic and mitral prosthetic valves, the EOA
should be calculated by the continuity equation method using the
stroke volume measured in the LVOT or rarely the right ventricular
outflow tract (RVOT) (Figures 7 and 8).103,108,109 EOA is a reflection
of the minimal cross-sectional area (CSA) of the transprosthetic
flow jet (the vena contracta), and it is calculated as:
EOA = CSA× VTILVOT/VTIPrV
= 0.785× (DLVOT)2 × VTILVOT/VTIPrV
EOA = Stroke volume
VTIPrV
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where the VTILVOT is the velocity time integral of blood flow in the
LVOT, measured with pulsed wave (PW) Doppler in the LVOT just
proximal from the aortic valve (apical views) or rarely the pulmonic
valve (short-axis view); and the VTIPrV is the velocity time integral
through the prosthetic valve determined by continuous wave
(CW) Doppler. The pulmonic site to calculate the stroke volume
is rarely used but useful if the LVOT cannot be evaluated.19
The continuity method requires that the velocity utilized for the
stroke volume calculation is the spatial mean velocity, which is
obtained by moving the sample volume approximately 0.5 cm
away from the prosthesis sewing ring towards the LV apex.19 The
principle is that the LVOT diameter and velocity derive from almost
the same anatomic location. The sample volume position is optimal
if the signal contains a nice spectral envelope and the closing click of
the prosthesis (in case of aortic prosthesis). The VTI is obtained by
tracing the contour of the Doppler flow signal. The peak velocity
may be used instead of the VTI in the continuity equation.19 The
VTIPrV is recorded from the same transducer position (apical five-
or three-chamber, right parasternal, or suprasternal window with
TTE or transgastric position at 908 to 1208 or a deep transgastric
‘upside-down view’ at 08 to 208 with TOE). The measurement of
the LVOT diameter (parasternal long-axis zoomed view with TTE
or 1208 view with TOE) is often challenging in the presence of an
aortic prosthesis because of the reverberations and shadowing
caused by the prosthesis components. Particular attention should
be paid not to mistake the inner border of the prosthesis stent/
ring for the inner edge of the LVOT. Any error in the measurement
of LVOT diameter will be squared in the calculation of the EOA. For
an LVOT diameter of 2.0 cm, a 10% error in measurement (1.8 cm)
results in a 19% error in calculated EOA. It is important to empha-
size that the substitution of the LVOT diameter by the labelled pros-
thesis size in the continuity equation is not a valid method to
determine the EOA of aortic prostheses.109 For aortic prostheses,
this method is also valid in the presence of concomitant prosthetic
regurgitation. However, for mitral prostheses, the continuity equa-
tion method cannot be applied when there is .mild concomitant
mitral (MR) or aortic regurgitation (AR). In some cases, volumetric
method can be used when the conventional 2D-Doppler method is
not feasible/reliable. In ‘normally functioning’ prostheses, the EOA
should fall into in the normal reference for that prosthetic valve
type and size (Tables 7 and 8).
The pressure half time (PHT) method is not valid for estimating
the EOA of mitral prostheses.103 The time for the initial transpros-
thetic gradient to decline to half of its initial value is not only related
to the prosthetic valve area but also to the pressure gradient at the
start of diastole and to LV and left atrial compliance.19 Nonetheless,
the PHT may be useful if it is significantly delayed or shows signifi-
cant lengthening from one follow-up visit to the other despite simi-
lar heart rates.14
Doppler velocity index
The DVI can be helpful to screen for prosthetic valve stenosis, par-
ticularly when reliable measure of the LVOT diameter cannot be ob-
tained to calculate the EOA by the continuity equation method.110
This index is less dependent on valve size because of the linear re-
lationship of the implanted valve size to the size of the LVOT. For
aortic prostheses, the DVI is calculated as the ratio of the proximal
peak flow velocity (or VTI) in the LVOT to the transprosthetic peak
flow velocity (or VTI). For a normally functioning aortic prosthesis,
the DVI is typically .0.30–0.35.14





For prosthetic mitral valves, DVI is calculated as:
DVI = VTIPrV
VTILVOT
It is normally ,2.2 for mechanical mitral valves.
Parameters of flow ejection dynamics
Parameters of flow ejection dynamics measured on the CW Dop-
pler signal of the transprosthetic flow velocity (Figure 7, Panel C )
are angle-independent parameters that can also help to distinguish
between normal PHV function [with or without patient-prosthesis
mismatch (PPM)] vs. acquired PHV stenosis.111 In a normal aortic
native or prosthetic valve, the contour of the CW flow velocity
Figure 7 Aortic prosthesis EOA calculation using the continuity
equation. The LVOT diameter is measured in mid-systole from the
parasternal long-axis view in a zoomed mode, from inner-edge to
inner-edge (A). The cross-sectional area (CSA) of the LVOT is cal-
culated from the LVOT diameter assuming that the LVOT is circu-
lar (CSA ¼ P × LVOTd2/4). The stroke volume across the
prosthesis is computed from multiplying the CSA of the LVOT
with the velocity-time integral (VTI) of the LVOT (B). The EOA
of the prosthesis is then calculated by dividing the stroke volume
by the VTIPrV of the transprosthetic flow obtained with continuous
wave Doppler (C).
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Figure 8 Mitral prosthesis EOA calculation using the continuity equation. The stroke volume across the aortic valve is calculated as described in
Figure 7, Panels (A) and (B). The EOA of the mitral prosthesis is calculated by dividing the left ventricle stroke volume by the VTIPrV of the trans-
prosthetic flow obtained with continuous wave Doppler (C and D).
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Table 7 Normal reference values of effective orifice areas for the prosthetic aortic valves
Prosthetic valve size (mm) 19 21 23 25 27 29
Stented bioprosthetic valves
Mosaic 1.1+0.2 1.2+0.3 1.4+0.3 1.7+0.4 1.8+0.4 2.0+0.4
Hancock II – 1.2+0.2 1.3+0.2 1.5+0.2 1.6+0.2 1.6+0.2
Carpentier-Edwards Perimount 1.1+0.3 1.3+0.4 1.5+0.4 1.8+0.4 2.1+0.4 2.2+0.4
Carpentier-Edwards Magna 1.3+0.3 1.5+0.3 1.8+0.4 2.1+0.5 – –
Biocor (Epic) 1.0+0.3 1.3+0.5 1.4+0.5 1.9+0.7 – –
Mitroflow 1.1+0.2 1.2+0.3 1.4+0.3 1.6+0.3 1.8+0.3 –
Trifecta 1.4 1.6 1.8 2.0 2.2 2.4
Stentless bioprosthetic valves
Medtronic Freestyle 1.2+0.2 1.4+0.2 1.5+0.3 2.0+0.4 2.3+0.5 –
St Jude Medical Toronto SPV – 1.3+0.3 1.5+0.5 1.7+0.8 2.1+0.7 2.7+1.0
Prima Edwards – 1.3+0.3 1.6+0.3 1.9+0.4 – –
Mechanical valves
Medtronic-Hall 1.2+0.2 1.3+0.2 – – – –
St Jude Medical Standard 1.0+0.2 1.4+0.2 1.5+0.5 2.1+0.4 2.7+0.6 3.2+0.3
St Jude Medical Regent 1.6+0.4 2.0+0.7 2.2+0.9 2.5+0.9 3.6+1.3 4.4+0.6
MCRI On-X 1.5+0.2 1.7+0.4 2.0+0.6 2.4+0.8 3.2+0.6 3.2+0.6
Carbomedics Standard and Top Hat 1.0+0.4 1.5+0.3 1.7+0.3 2.0+0.4 2.5+0.4 2.6+0.4
ATS Medicala 1.1+0.3 1.6+0.4 1.8+0.5 1.9+0.3 2.3+0.8 –
Effective orifice area is expressed as mean values available in the literature. Further studies are needed to validate these reference values.
aFor the ATS medical valve, the label valve sizes are 18, 20, 22, 24, and 26 mm. High velocities are common in size 19 or 21 prostheses. Adapted with permission from Ref. 7.
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through the prosthesis generally has a triangular shape, with early
peaking of the velocity and a short (,100 ms) acceleration time
(AT) (i.e. the time from the onset of flow to maximal velocity,
Figure 7, Panel C). However, the acceleration time is highly depend-
ent on heart rate. To overcome this limitation, it is recommended to
index the AT to the LV ejection time.
Pressure recovery and localized high gradient
Several studies have reported that Doppler may overestimate the
gradient across native, mechanical, or bioprosthetic aortic valves
compared with catheter measurements.100,112 – 115 As blood flow
velocity decelerates between the aortic valve and the ascending aor-
ta, part of the kinetic energy is reconverted back to static pressure
energy. This phenomenon is called pressure recovery. Most of the
kinetic energy is dissipated in heat as a result of turbulence. Hence
the net gradient between the LV and the ascending aorta (i.e. the
gradient measured by catheter) is less than the maximum pressure
gradient measured by Doppler at the level of the vena contracta.
The ratio between the valve EOA and the cross-sectional area of
the downstream chamber, i.e. the ascending aorta in the case of na-
tive or prosthetic aortic valves, determines the extent of pressure
recovery. Hence, pressure recovery generally becomes clinically
relevant in patients with smaller aortas, i.e. with an aorta diameter
at the sino-tubular junction ≤30 mm.100,112 –115 In these patients, it
is thus appropriate to account for pressure recovery by using the
simple formula proposed by Garcia et al.112 to calculate the energy
loss coefficient: ELC¼(EOA × AA/AA 2 EOA), where AA is the
cross-sectional area of the aorta measured at 1 cm downstream
of the sino-tubular junction. The energy loss coefficient should be
indexed for body surface area (i.e. energy loss index) to account
for the change in cardiac output related to body size. Pressure re-
covery generally does not occur in the case of mitral prostheses, be-
cause the size of the downstream chamber (i.e. the LV) is large
relative to the EOA of the prosthesis.
The downstream pressure recovery phenomenon is distinct from
another mechanism responsible for localized high gradients within
the central orifice of bileaflet mechanical valves.100,113,116,117 This
may yield to overestimation of gradient (average of 4 to 11% com-
pared with catheterization) and underestimation of EOA regardless
of the position (aortic or mitral) of the prosthesis. Because the cen-
tral orifice is smaller than the lateral orifices, the blood flow velocity
may be locally higher within the inflow aspect of the central orifice
and continuous-wave Doppler may record this high velocity. The
prevalence, magnitude, and predictors of this phenomenon are not
fully understood, but it is probably related to PHV size (smaller
size, higher velocity) and design (ratio of the size of the central orifice
to that of lateral orifices) and flow conditions (higher flow, higher vel-
ocity).100,113,116,117 Given that localized high-velocity region is very
small and located at the inflow of the central orifice, the recording
of this velocity is highly inconsistent and may vary from one patient
to the other and even from one visit to the other in a given patient,
depending on the direction and angulation of the Doppler beam.
Physiologic regurgitation (retrograde flows)
Mechanical valves have a normal regurgitant volume that may
include either a backflow related to the backward motion of
the occluder(s) (i.e. the closing volume), a leakage backflow
through the components of the prosthesis (leakage volume) or
both.7,14,80 – 82,94 – 96 This ‘built-in’ regurgitation theoretically
prevents blood stasis and thrombus formation by a washing effect.
Minor regurgitation is thus normal in virtually all mechanical valves.
As opposed to pathologic regurgitant jets, the normal leakage back-
flow jets are characterized by being narrow at their origin and sym-
metrical and low in momentum (i.e. usually have a homogeneous
colour without significant aliasing). They are also characterized by
the absence of supporting features like increased anterograde
velocity, enlargement of cardiac chambers, or pulmonary hyperten-
sion. Of note, mild central leakage may be seen in normally function-
ing bioprosthetic valves.7,14
‘Caged-ball mechanical prostheses’ have a small amount of nor-
mal regurgitant flow (closing volume of 2–6 mL per beat).
‘Monoleaflet mechanical’ valves have small physiologic regurgitant
volume (5–9 mL per beat) that includes the closing volume as well
leakage backflow through small gaps around the perimeter of the
valve. In the Medtronic-Hall valves, there is also often a small
amount of regurgitation around the central strut.
‘Bileaflet mechanical valves’ typically have a small amount (5–
10 mL per beat) of normal regurgitation. On Doppler colour flow
imaging, two main regurgitant jets originating from the pivot points
of the valve disks which may break into one or more ‘plumes’ and a
smaller central jet are often seen (Figure 2, Panel G and I ). Smaller jets
around the closure rim of the leaflets may also be seen.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 8 Normal reference values of effective orifice areas for the prosthetic mitral valves
Prosthetic valve size (mm) 25 27 29 31 33
Stented bioprosthetic valves
Medtronic Mosaic 1.5+0.4 1.7+0.5 1.9+0.5 1.9+0.5 –
Hancock II 1.5+0.4 1.8+0.5 1.9+0.5 2.6+0.5 2.6+0.7
Carpentier-Edwards Perimount 1.6+0.4 1.8+0.4 2.1+0.5 – –
Mechanical valves
St Jude Medical Standard 1.5+0.3 1.7+0.4 1.8+0.4 2.0+0.5 2.0+0.5
MCRI On-Xa 2.2+0.9 2.2+0.9 2.2+0.9 2.2+0.9 2.2+0.9
Effective orifice area is expressed as mean values available in the literature. Further studies are needed to validate these reference values.
aThe On-X valve has just 1 size for 27 to 29 and 31 to 33 mm prostheses. In addition, the strut and leaflets are identical for all sizes (25 to 33 mm); only the size of the sewing cuff is
different. Adapted with permission from Ref. 7.
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A small degree of central (at the point of apposition or close to
the commissures) regurgitation (,1 mL) is also often observed in
‘bioprosthetic valves’ and more frequently in bovine pericardial
valves. Stentless valves, including homografts and autografts, are
more likely than stented valves to have minor regurgitant jets.
Key points
All normal functioning mechanical PHVs cause some degree of obstruction to
blood flow, closure backflow (necessary to close the valve), and leakage
backflow (after valve closure). Quantitative parameters of PHV function
include transprosthetic flow velocity and pressure gradients, EOA and DVI.
Although good correlation exists between Doppler and invasive
measurements, overestimation of pressure gradients by Doppler is frequent
in mechanical PHVs. Comparison of the haemodynamic function of different
designs of valve cannot be made using label size. The label size cannot be




Structural valve deterioration results in stenosis or regurgitation
through the valve.7,118,119
For ‘mechanical valves’, haemodynamic dysfunction can occur as a
result of strut fracture, occluder fracture or escape, loss of leaflet
mobility (not due to thrombus, pannus, or vegetation) or ball vari-
ance (due to lipid adsorption on the ball of old model Starr-Edwards
valves), sewing cuff separation from housing.7,118
For ‘bioprosthetic valves’, haemodynamic dysfunction (stenosis
or regurgitation) usually occurs with calcification or tearing of
the cusps but occasionally fracture of the stent sewing cuff separ-
ation from stent, or valve deformation.
Non-structural and other causes of valve
dysfunction
Non-structural dysfunction is any abnormality not intrinsic to the
valve itself and includes dehiscence or entrapment of the occluder
by pannus, tissue, or suture (Table 9).17,120
Thrombus formation is the most common cause of obstruction of
mechanical prostheses (0.3 to 8% per patient-year). Although
less frequent and more insidious, it can also be observed in
bioprosthesis. The incidence of pannus formation causing prosthesis
obstruction is similar in biological and mechanical prosthesis.
Mitral and tricuspid prostheses are associated with, respective, 7.5
and 11.7 times higher hazard risk of thrombosis and the risk of
pannus formation is three times larger in the mitral position. Large
prosthesis size (.27 mm), tilting disk, and bileaflet prostheses
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Table 9 Definitions of morbidity after heart valve replacement surgerya
Complication Definition Examples or notes
Structural valve
deterioration
Deterioration or dysfunction of the operated valve caused by
changes intrinsic to the valve
(1) Mechanical valve—wear, fracture, poppet escape
(2) Biological valve—calcification, leaflet tear, stent creep
(3) Both—disruption of components of a prosthetic valve
Non-structural
dysfunction
Any abnormality not intrinsic to the valve that results in
stenosis or regurgitation of the valve or haemolysis
(1) Entrapment by pannus, tissue, or suture
(2) Paravalvular leak
(3) Inappropriate sizing or positioning
(4) Residual leak or obstruction after valve implantation
(5) Clinically important intravascular haemolysis
(6) Dilatation of aorta or aortic annulus causing aortic regurgitation
(for stentless valves)
Valve thrombosis Any thrombosis not caused by infection that occludes part
of the blood flow path, interferes with valve function, or is
sufficiently large to warrant treatment
Embolism An embolic event that occurs in the absence of infection after
the immediate perioperative period
(1) Stroke (.72 h neurological deficit) or non-specific symptoms
with brain imaging demonstrating an acute ischaemic event
(2) TIA (fully reversible symptoms of short duration with no
abnormality on brain imaging)
(3) Non-cerebral embolic event (not perioperative myocardial
infarct)
Bleeding event Any episode of major internal or external bleeding that
causes death, hospitalization, permanent injury, or blood
transfusion
Exclude bleeding associated with major trauma or an operation.
Include major unexpected bleeding associated with minor trauma.
Endocarditis Proved infection of the replacement heart valve Proof by:
(1) Reoperation with evidence of abscess or other local
complication
(2) Autopsy evidence of abscess, pus, or vegetation
(3) Duke criteria positive
aBased on definitions in Akins et al.119
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are associated with, respective, 67, 69, and 83% risk reduction of
thrombosis.120
Differentiation between thrombosis and pannus overgrowth re-
mains challenging. Recent onset of dyspnoea or of an embolic event
and a history of subtherapeutic anticoagulation are suggestive of ob-
structive valve thrombosis. The thrombus tends to be mobile and
globular with a soft echo density (similar to that of the myocardium)
and may be attached to the valve occluder or sewing ring or both
(Figure 9). Pannus is firmly fixed, has a bright echo density (small
dense mass with the same echo intensity as the valve housing),
and is attached to the valve apparatus (valve housing and pivot
guards) (Figure 10).121 The situation is further complicated, because
pannus may induce thrombus formation. On cardiac CT, thrombus
has lower measured CT attenuation values than pannus, with a sug-
gested threshold of 200 HU to distinguish either (Table 10).53,61
Pathologic PHV regurgitation
Pathologic regurgitation is either central or paravalvular.11,16,20,21
Most pathologic central regurgitations are seen with biologic valves
as a sign of structural valve degeneration. A pathological jet is often
first seen close to the commissure at a site of an early tear in the
leaflet. This may then progress on serial studies. Regurgitation
through a mechanical valve may be seen with mechanical
interference with closure, for example, by pannus, thrombus, vege-
tation, or more rarely a chordae. Disappearance of physiological re-
gurgitation and the presence of a new central regurgitation are
typically observed in acute thrombosis of mechanical valves.
The incidence of paravalvular regurgitation is similar in mechanical
and biological valves. Paravalvular regurgitation depends on
numerous factors including surgical technique, the size and compos-
ition of the sewing ring and the position of the valve (annular vs.
supra-annular), and the quality of the patient’s tissues. In the mitral
position, it occurs mainly in the posterior and anterior regions. Most
are apparent in the immediate postoperative study and occur
because of technical problems at the time of surgery including the
presence of friable tissue. Late dehiscence is often a sign of infective
endocarditis. Less commonly, the integrity of the original suture
line could be compromised by usual wear- or age-related deterior-
ation of the surrounding tissue.
Localization of paravalvular regurgitation may be difficult and is
only possible with confidence if a trail of flow can be visualized
around the outside of the sewing ring. Although paraprosthetic re-
gurgitation is abnormal, small jets are not uncommon especially dur-
ing perioperative examination early after surgery. Immediately
following implantation, the prevalence of paravalvular regurgitation
ranges between 5 and 20%.122 However, the majority of these leaks
Figure 9 Mechanical valve in mitral position and thrombus obstruction. Increased transprosthetic mean pressure gradient (MPG) over a mech-
anical valve in mitral position (D), as assessed from the transoesophageal view and related to the presence of a thrombus (A and B, white arrows).
Flow acceleration due to the obstruction at the level of the prosthesis is seen by colour flow imaging (orange arrow, B). Another example of a
thrombotic mass on the atrial side of the prosthesis blocking its medial orifice (C, white arrow). A schematic representation is summarized in E.
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are clinically and haemodynamically insignificant and, in the absence
of endocarditis, have a benign course. There is no evidence that they
increase the risk of endocarditis, but on occasion, they may cause
haemolytic anaemia due to red cell destruction.123
Imaging evaluation of PHV dysfunction
Both qualitative and quantitative assessments are recommended.
Excessive motion of the sewing ring may be a clue to valvular dehis-
cence.7,122 A rocking motion of.158 of sewing ring excursion is ab-
normal.14 However, usually rocking in the aortic position implies a
large dehiscence, 40% of the sewing ring. Unlike in the aortic pos-
ition, rocking of the sewing ring may occur as a result of retention of
the native posterior leaflet, but a true dehiscence is obvious from
the gap opening between annulus and sewing ring and by the pres-
ence of an overlaying jet on colour mapping. Structural deterior-
ation of a bioprosthetic valve should be suspected whenever
increased valvular regurgitation or stenosis develops.
When PHV obstruction is suspected, imaging assessment should
look for (i) thickening of the leaflets in biological prosthesis, or the
presence of a mass limiting the movement of the occluders in
mechanical prosthesis; (ii) decreased motion of the disc, ball, or
leaflet; (iii) restriction of the colour flow at the PHV orifice; (iv)
haemodynamic impairment and ventricular consequences (Doppler
echocardiography) (Table 11).
Generally, the same principles and methods used for quantifica-
tion of native valvular regurgitation, detailed in a previous
document, can be used for PHVs, but are more challenging
(Figures 11–15).20,21 In fact, there are very limited data on the
application and validation of these parameters (e.g. vena contracta
width, EROA, RVol) in the context of PHVs. Moreover, the fre-
quent eccentricity of regurgitant jets, the presence of multiple
jets, and the shadowing effects due to prosthetic materials make
detection and quantification more difficult or limited. Indirect
clues from various colour Doppler parameters can suggest the
presence of significant regurgitation (i.e. turbulent jet at the roof
of LA below the acoustic shadow). Transvalvular jets should be
distinguished from paravalvular regurgitations (Figure 16). At pre-
sent, integrating multiple qualitative, semi-quantitative, and quanti-
tative findings is the recommended approach for assessing PHV
regurgitation.14
Patient-prosthesis mismatch
PPM occurs when the EOA of a normally functioning prosthesis is
too small in relation to the patient’s body size (and thus to cardiac
Figure 10 Mechanical valve in aortic position and pannus. Flow acceleration of the anterograde flow is identified with colour flow imaging from
the transthoracic apical approach (A). High-pressure gradients are documented with continuous wave Doppler from the same approach, mean
pressure gradient (MPG) 36 mmHg (B). 2D transoesophageal echocardiography enforces the suspicion of prosthesis obstruction by revealing a
hyperechogenic mass on the prosthesis (C and D, white arrows). Cinefluoroscopy shows abnormal opening and closing angle for this type of pros-
thesis (E and F). Cardiac computed tomography (CT) scan is in favour of a pannus ingrowth on the prosthesis that blocks the normal movement of
the tilting disks (G, H, and I, white arrows). A schematic representation is summarized in J.
P. Lancellotti et al.Page 20 of 47






output requirements), resulting in abnormally high postoperative
gradients (i.e. mean gradient .20 mmHg).103,124 Hence, PPM is
not an intrinsic prosthesis dysfunction per se. The identification of
PPM and its differentiation from dysfunction is achieved by calculat-
ing the projected indexed EOA, i.e. the normal reference value of
EOA for the model and size of the prosthesis (Tables 7 and 8)
divided by patient’s body surface area. Table 12 shows the cut-off
values of indexed EOA generally used to identify and quantify the
severity of PPM.
Moderate PPM may be quite frequent both in the aortic
(20–70%) and in the mitral (30–70%) positions, whereas the
prevalence of severe PPM ranges from 2 to 10% in both positions.125
PPM is associated with worse haemodynamics, slower and less com-
plete regression of LV hypertrophy and pulmonary hypertension,
worse functional class, exercise capacity, and quality of life, more
cardiac events, and lower survival.126 – 128 PPM also predispose to
faster degeneration of bioprosthetic valves following aortic valve
replacement.129,130
The other findings supportive of the presence of PPM are
(Table 12) (i) the measured EOA is within 1 standard deviation or
within 0.25 cm2 of the normal reference EOA; (ii) the measured
indexed EOA is lower than the aforementioned cut point values;




† Velocity time integral (VTI)
† Doppler velocity index (DVI)
† Effective orifice area (EOA) by the continuity equation
† Presence, location, and severity of regurgitation
† +LV size and function, LV hypertrophy (a hyperdynamic LV is a useful
indirect sign of severe aortic regurgitation), aorta (most likely to continue
to dilate if dilated at the time of surgery)
† + Other valves: appearance, grade of stenosis, and regurgitation
Mitral position
† Peak velocity
† Mean pressure gradient
† Velocity time integral (VTI)
† Doppler velocity index (DVI)
† Effective orifice area (EOA) by the continuity equation
† Pressure half time
† Presence, location, and severity of regurgitation
† +LV size and function, LA size, estimated systolic pulmonary artery
pressure (a hyperdynamic LV is a useful indirect sign of severe mitral
regurgitation); (pulmonary hypertension may be a sign of mitral
dysfunction)
† +Other valves: appearance, grade of stenosis, and regurgitation
Pulmonary position
† Peak velocity
† Peak and mean pressure gradient
† Presence, location, and severity of regurgitation
† +RV size and function, estimated systolic pulmonary artery pressure
† +Other valves: appearance, grade of stenosis, and regurgitation
Tricuspid position
† Peak velocity
† Mean pressure gradient
† Velocity time integral (VTI)
† Doppler velocity index (DVI)
† Pressure half time
† Presence, location, and severity of regurgitation
† +RV size and function, RA size, IVC size, hepatic venous flow, estimated
systolic pulmonary artery pressure
† +Other valves: appearance, grade of stenosis, and regurgitation
IVC, inferior vena cava; LV, left ventricle; RA, right atrial; RV, right ventricle.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 10 Differential diagnosis: pannus vs. thrombosis
Pannus Thrombosis
Chronology Minimum 12 months, commonly .5 years
from surgery date
Occurs at any time (if late usually
associated with pannus)
Relation to anticoagulation (low INR) Poor relationship Strong relationship
Location MV.AV TV.. MV ¼ AV
Morphology † Small mass
† Mostly involve suture line (Ring)
† Centripetal growth
† Confine to the disk plane
† Growth beneath disc
† Larger mass than pannus
† Independent motion common
† Thin outer ring maybe visible
† Project into LA for MV position
† Mobile elements
Echo density (video-intensity ratio) More .0.7 (100% specific) Less (,0.4)
Cardiac CT: attenuation value .200 HU ,200 HU
Impact on gradient AV. MV MV.AV
Impact on valve orifice AV. MV MV.AV
Impact on disc motion Yes/no Yes
AV, aortic valve; LA, left atrial; MV, mitral valve; TV, tricuspid valve.
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(iii) the valve leaflet morphology and mobility are normal; (iv) the PPM
is present early after surgery and on all subsequent echocardiograms.
There are however some specific caveats in the assessment of
PPM: (i) the use of the EOA indexed for body surface area may over-
estimate the severity of PPM in obese patients (body mass index
≥30 kg/m2).131 It is thus recommended to use lower cut point va-
lues of indexed EOA to identify moderate and severe PPM in obese
subjects (Table 12).132 Indexing the EOA by the fat free mass mea-
sured by a bio-impedance scaler may provide an interesting alterna-
tive avenue, but this needs to be validated by further studies;
(ii) although PPM is the most frequent cause of high gradients fol-
lowing valve replacement, it is important to highlight that, in the
presence of low flow state, PPM may be associated with a normal
or low gradient. Indeed as for native valve stenosis, low-flow states
are often associated with pseudo-normalization of transvalvular
flow velocities and gradients leading to underestimation of PPM
or prosthetic valve stenosis. Stress echocardiography may be useful
in this context to differentiate a true PPM or stenosis vs. normal
valve function; (iii) a large proportion of patients with aortic or mi-
tral prosthetic valves in fact have coexistence of PPM and acquired
stenosis or regurgitation. The criteria presented in Table 12 are
Figure 11 Aortic prosthetic regurgitation. An example of
pathological intraprosthetic regurgitation jet from a transoesopha-
geal 1208 view. The width of jet expansion into the left ventricular
outflow tract (red line) is compared with the width of the outflow
tract (white line). Of note, a part of the regurgitant flow is not seen
due to the prosthetic valve shadowing effect.
Figure 12 Severe paraprosthetic regurgitation of a mechanical prosthesis in aortic position as assessed by 3D and 2D transoesopgaheal echo-
cardiography (TOE). From a modified 1208 approach, the paraprosthetic regurgitant jet can be seen by colour flow imaging (A, B, and C ). Note that
a clear regurgitant jet convergence zone and a nicely defined vena contracta (B, yellow arrows) of the regurgitant jet can be observed. The radius of
the proximal isovelocity surface area (PISA) (C, red line) can be measured, and with the PISA method, the effective regurgitant orifice area (EROA)
and the regurgitant volume (R Vol) can be calculated (D). From the transthoracic approach, there is a holodiastolic flow reversal in the descending
thoracic aorta (Desc. Ao) with an end-diastolic velocity (EDVel .20 cm/s, E). The PHT is shortened (F ).
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related to pure PPM with no concomitant dysfunction. In the pres-
ence of acquired stenosis, the EOA is significantly below these va-
lues and the leaflet morphology/mobility is generally abnormal.
The projected indexed EOA is the only parameter that is valid to
identify and quantitate PPM in the presence of concomitant stenosis.
If there is doubt, CT or cinefluoroscopy can support echocardiog-
raphy in the diagnosis of pure PPM by showing normal leaflet func-
tion, the absence of masses, and small GOA (Figures 17 and 18).130
Key points
PPM should be distinguished from PHV dysfunction. PPM is present early after
surgery and on all subsequent echocardiograms. The echocardiographic
diagnosis of pannus formation is often a diagnosis of exclusion but may be
detected better by CT. At present, integrating multiple qualitative,
semi-quantitative, and quantitative findings is the recommended approach
for assessing PHV regurgitation.
Follow-up and monitoring
Patients who have recently undergone valve replacement should
not be considered as cured and require careful and, when necessary,
frequent follow-up.133 Ideally, a comprehensive baseline TTE should
be obtained at the first postoperative visit usually after 4–6 weeks
when the chest wound has healed, chest wall oedema has resolved,
and LV systolic function has recovered. However, if the patient is
being transferred to another hospital’s care and may not return, it
may be better to perform the study before discharge. It is then
not recommended to perform routine scans in asymptomatic pa-
tients with normally functioning mechanical valves or until 5 (ESC)
to 10 (ACC/AHA) years after implantation for those with normally
functioning biological valves.4,5 However, it is suggested that routine
TTE should still be performed annually for (i) new designs of bio-
logical valve for which durability data are not established; (ii) patients
with aortic dilatation at the time of surgery; (iii) patients after
Figure 13 Severe intraprosthetic regurgitation of a bioprosthesis in mitral position (A). Note the anterograde turbulent jet (B, white arrow)
due to the high blood volume (normal anterograde flow + regurgitant volume) passing through the prosthesis. Consequently, the peak velocity of
the early diastolic flow is increased (E ¼ 2.6 m/s) in relation to the increase in flow (E). With colour flow Doppler, and by shifting the baseline into
the direction of the regurgitant jet, a clear regurgitant jet convergence zone and a nicely defined vena contracta (C, yellow arrows) of the regur-
gitant jet can be observed. The radius of the proximal isovelocity surface area (PISA) (D, white line) can be measured, and with the PISA method
the effective regurgitant orifice area (EROA) and the regurgitant volume (R Vol) can be calculated (F). Moreover, the analysis of the pulmonary
vein flow pattern shows reversal of the systolic S wave (I), indicative of severe regurgitation. Same regurgitation from 2D and 3D transoesphageal
approach (G and H).
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left-sided mitral valve replacement [to check for the development of
tricuspid regurgitation (TR) and RV dysfunction]. Echocardiography
also becomes indicated if symptoms develop or in case of signs
suggesting valve dysfunction or alteration (i.e. thickening of a bio-
prosthesis, which can represent an early sign of structural valve dys-
function). When TTE/TOE is inconclusive, additional imaging
approaches (cinefluoroscopy, cardiac CT, CMR) can be indicated.
Valve-specific approach
Aortic prosthetic valve
Baseline assessment and serial reports
Several clinical and Doppler echocardiographic findings should
be reported when assessing aortic PHV function (Tables 4
and 10).7,14 They include (i) measurement of blood pressure;
(ii) evaluation of valve morphology and function; (iii) estimation of
prosthetic pressure gradients and flow velocities, DVI, EOA; (iv) as-
sessment of regurgitation severity (physiologic/pathologic/central/
paravalvular), if present; (v) evaluation of LV size and function; (vi)
estimation of pulmonary pressure. The measured value of LVOT
and the acoustic window that provides the highest aortic jet velocity
are documented. Values should be compared with the normal
Doppler data available for each prosthetic valve subtype and size,
and the presence of PPM should be noted. The need, the type,
and the reason for other imaging approaches required during
follow-up should be mentioned. Any changes in aortic PHV morph-
ology and function parameters are documented.
Imaging assessment
Effort should be made to image all portions of the aortic PHV.
This involves imaging of the sewing ring, cusps, stents, the occluder(s),
and surrounding areas. Echocardiography is the first-line imaging but
cinefluoroscopy, cardiac CT, or occasionally CMR can be used
when echocardiography is inconclusive (see above).15,21,29,40,49,63 On
TTE, all standard views must be used. Colour Doppler imaging is used
to confirm the presence of normal anterograde flow and to demon-
strate the expected washing jets.7,14 Colour Doppler is used to rule
out the presence of pathologic valvular or paravalvular jets. The entire
circumference of the valve’s sewing ring must be assessed. The motion
of the cusps or occluder is imaged using parasternal long- and short-
axis and the apical three- and five-chamber views. The stents of
biological valve are often well seen in the parasternal long-axis view.
Careful orientation of the ultrasound beam parallel to the direction
of the occluder opening can reduce acoustic shadowing across the
plane of the valve and improve occluder visualization. This is
Figure 14 Echocardiographic evaluation of a severe bioprosthesis in tricuspid position (A). With colour flow Doppler, and by shifting the base-
line into the direction of the regurgitant jet, a clear regurgitant jet convergence zone and a nicely defined vena contracta (B, C, and D) of the re-
gurgitant jet can be observed. The radius of the proximal isovelocity surface area (PISA) (D, white line) can be measured, and with the PISA method
the effective regurgitant orifice area (EROA) and the regurgitant volume (R Vol) can be calculated (E). Moreover, the analysis of the hepatic vein
flow pattern shows reversal of the systolic (S) wave (F ), indicative of severe regurgitation.
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particularly useful for the apical views. Of note, the origin of prosthesis
AR (central vs. paravalvular) is best imaged in the parasternal short-
axis view. Paravalvular regurgitant jets located posteriorly are however
often totally or partially masked in the parasternal long-axis or short-
axis views because of the shadowing caused by the prosthetic valve
stent. Apical views should thus be carefully examined to properly de-
tect and quantitate these posterior jets. On TOE, the reference view is
at mid-oesophageal level usually with a rotation to 458 and 1208 to
obtain a short- and long-axis visualization of the valve, showing closure
and opening of the aortic cusps or movement of the occluder, and the
presence of AR.15,134 The long-axis view (TTE and TOE) permits visu-
alization of the LVOT, the aortic annulus, the aortic cusps, the sinuses
of Valsalva, the sino-tubular junction, and the first centimetres of the
tubular aorta. Deep transgastric TOE views at 08 image are also used
to evaluate the LVOT, the prosthesis, and the proximal part of the aor-
ta. With TOE, anterior regurgitant jets may be under-detected or un-
derestimated in some views due to the shadowing phenomenon. The
jets located on the lateral or medial aspects of the aortic PHVs are of-
ten difficult to visualize in the standard TTE and TOE views, and it is
necessary to obtain off-axis/intermediary views to reveal these jets.
3D echocardiography, especially during TOE, is ideal for imaging the
entire aortic prosthesis, the whole sewing ring, and the extent of
any paravalvular leak (Figure 16).22–24
Valve morphology and function
Aortic PHV dysfunction, stenosis and/or regurgitation, is generally
associated with abnormal valve morphology and/or mobility. Im-
aging may demonstrate the aetiology of dysfunction by showing
evidence of leaflet degeneration [thickening (.3 mm), calcification,
abnormal mobility] in bioprostheses, abnormal occluder/disc mo-
tion in mechanical PHVs, or excessive motion of the sewing ring.
If the cusps are thickened or if the occluder has reduced opening,
then the valve is likely to be obstructed. Conversely, if the cusps
and occluder are thin and open normally, then the valve is likely
to be normal provided that pannus can be excluded. The sutures
or small fibrin strands may be visible. Early after implantation, an aor-
tic haematoma and oedema can be observed in stentless valve.
Acquired aortic PHV obstruction
Doppler assessment
Doppler ultrasound assessment (CW and pulsed wave) of aortic
PHVs is obtained from the apical positions and completed by the in-
terrogation of the right parasternal, suprasternal, and sub-costal
views (to measure the highest velocities). CW Doppler signal across
the normal aortic PHV usually shows a peak velocity .2 m/s occur-
ring in early systole with a short acceleration time, i.e. the time from
the onset of flow to maximal velocity (AT,80 ms), and a triangular
envelope.30,87,111 Increasing grades of obstruction are associated
with increasing mean transaortic gradients and peak velocities that
occur late in systole with longer AT relative to LV ejection duration
and a more rounded Doppler signal (Figure 19).
Transaortic gradients and velocities are influenced by prosthesis
size, stroke volume, and the presence of PPM or of any obstruction.
For example, increased mean transaortic gradients can be observed
in small prostheses and in patients with moderate or severe PPM,
whereas in patients with severe stenotic aortic PHV, the transaortic
Figure 15 Examples of moderate (A) and severe (B) intraprosthetic pulmonary regurgitation after a Ross procedure. Colour flow Doppler
shows a intraprosthetic central regurgitation jet with a narrow vena contracta width, and continuous wave Doppler (CWD) reveals a faint incom-
plete signal (A), as opposed to a larger vena contracta width and an intense CWD signal and a short PHT in case of severe regurgitation (B).
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gradients may be only mildly elevated if concomitant severe LV dys-
function (low flow state) is present. To overcome these limitations,
other Doppler-based parameters have been proposed: the AT and
the ratio between the AT and the ejection time (ET). An AT
.100 ms and an AT/ET ratio .0.37 suggest the presence of aortic
PHV stenosis with a good accuracy.30,111 The advantage of these para-
meters is that they are independent of Doppler beam angulation in re-
lation to flow direction. On the other hand, the limitation of these
parameters is that they are influenced by LV systolic function and
chronotropy. Significant aortic PHV stenosis is usually associated
with increased transprosthetic peak flow velocity or mean gradient
during stress echocardiography (≥3 m/s or ≥20 mmHg).35,135
A change from earlier studies is another specific parameter of PHV
stenosis; an increase in mean gradient .10 mmHg or a fall in EOA
.25% during follow-up suggests clinically significant obstruction.
The measurement of the EOA and the DVI (VTILVOT/VTIPrV) pro-
vides a less flow-dependent evaluation of the prosthetic aortic valve
obstruction.19 Calculation of the EOA (stroke volume/VTIPrV) by
the continuity equation requires accurate estimation of the stroke
volume, which depends on precisely recording the LVOT diameter
and velocity (both derived from the same anatomical location), and
of the aortic jet velocity.14,25 Although values are to be referenced
against normal data for each prosthesis type and size, an EOA
,0.8 cm2 and a DVI ,0.25 raise the suspicion of significant aortic
PHV stenosis.
Integrative assessment
Echocardiographic detection and grading of aortic PHV obstruction
includes integration of data from 2D/3D imaging of the aortic valve
as well as qualitative and quantitative Doppler measures of
Figure 16 Examples of paraprosthetic aortic regurgitation (A, mild regurgitation; B, moderate to severe regurgitation) as assessed by multiplane
3D transoesophageal echocardiography.
P. Lancellotti et al.Page 26 of 47






Figure 17 Example of PPM in a patient with a mechanical valve in mitral position. There is an anterograde flow acceleration through the pros-
thesis as seen with colour flow imaging in C. The transprosthetic pressure gradients are high (mean pressure gradient of 11 mmHg, D). By applying
the continuity equation (A, B, and D), as explained in Figure 7, the EOA of this prosthesis is 1.2 cm2 (0.64 cm2/m2), suggesting together with the
high-pressure gradient and the increased DVI, either a valve obstruction or a PPM. However, cinefluoroscopy (E and F) shows normal closing and
opening angles, confirming the presence of a PPM.
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Table 12 Imaging criteria or the identification and quantitation of prosthesis-patient mismatch
Mild or not clinically significant Moderate Severe
Aortic prosthetic valves
Indexed EOA (projected or measured)
BMI ,30 kg/m2 .0.85 0.85–0.66 ≤0.65
BMI ≥30 kg/m2 .0.70 0.70–0.56 ≤0.55
Measured EOA vs. normal reference valuea Reference+1SD Reference+1SD Reference+1SD
Difference (reference EOA2 measured EOA) (cm2)a ,0.25 ,0.25 ,0.25
Valve structure and motion Usually normal Usually normal Usually normal
Mitral prosthetic valves
Indexed EOA (projected or measured)
BMI ,30 kg/m2 .1.2 1.2–0.91 ≤0.90
BMI ≥30 kg/m2 .1.0 1.0–0.76 ≤0.75
Measured EOA vs. normal reference valuea Reference+1SD Reference+1SD Reference+1SD
Difference (reference EOA2 measured EOA) (cm2)a ,0.25 ,0.25 ,0.25
Valve structure and motion Usually normal Usually normal Usually normal
See Tables 7 and 8 to obtain the normal reference values of effective orifice area for the different models and sizes of prostheses.
EOA, effective orifice area; BMI, body mass index; SD, standard deviation.
aThe criteria proposed for these parameters are valid for near normal or normal stroke volume (50–90 mL).
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obstruction severity. Other imaging modalities can also be used to
assess valve motion, structure, and function. Interpretation of the
data should be performed according to the date of valve replace-
ment, the prosthesis’ characteristics, and the haemodynamic condi-
tions. Table 13 lists the imaging parameters used to assess aortic
PHV function. When all parameters are normal, the likelihood of
valve dysfunction is very low. Conversely, when the majority of
the parameters are abnormal, the certainty of aortic PHV obstruc-
tion increases.
Differential diagnosis of high-pressure gradients
A high transprosthetic velocity or gradient alone is not a proof of
PHV obstruction and may be secondary to PPM, high flow condi-
tions (e.g., post-op period, anaemia, sepsis), occult mitral prosthesis
regurgitation, aortic PHV regurgitation, the phenomenon of rapid
pressure recovery, technical errors, or localized high central jet vel-
ocity in bileaflet mechanical valves.7 The flow dependency of pres-
sure gradients highlights the need for a stepwise approach including
EOA and DVI estimation. The retain algorithm for interpreting these
high gradients is derived from a compilation of previously suggested
approaches (Figure 20).7,14,102,122,136 After having excluded possible
technical errors, the first step is to compare the EOA with the nor-
mal reference value of EOA for the type and size of prosthesis im-
planted. If the EOA is lower than the normal reference value, and
especially when there is a decrease in EOA and DVI or an increase
in mean gradient over serial studies, the presence of an abnormal
prosthesis motion in the context of a DVI ,0.25 and AT/ET
.0.37 suggests prosthetic valve obstruction. If the measured EOA
is close to the normal reference value, one can then calculate the
indexed EOA (EOA/BSA) using the measured EOA or alternatively
the normal reference value of EOA for the implanted valve (i.e. pro-
jected indexed EOA). If the result is ,0.85 cm2/m2, one can then
surmise that PPM is present and that depending on its degree of se-
verity, it may be partially or totally responsible for the high gradient.
In this context, it is important to keep in mind that both phenom-
enon, i.e. PPM and intrinsic dysfunction, may coexist. Of note,
PPM is present early after surgery and on all subsequent echocardio-




Using colour flow Doppler, the regurgitant jet into the LV during
diastole can be visualized from multiple views. Initial studies that de-
fined AR severity focused on characterization of the colour flow
jet.14,20 Methods that measured jet area or jet length have significant
limitations because of variations in haemodynamics, instrument set-
tings, receiving chamber characteristics, jet eccentricity, jet impinge-
ment on chamber walls, and variability in perception by readers.137
The colour jet area and length, which are weakly correlated to the
Figure 18 Example of PPM in a patient with a mechanical valve in aortic position. There is an anterograde flow acceleration through the pros-
thesis as seen with colour flow imaging in C. The transprosthetic pressure gradient is high (mean pressure gradient of 42 mmHg, D). By applying the
continuity equation (A, B, and D) as explained in Figure 1, the EOA of this prosthesis is found to be 1.01 cm2 (0.52 cm2/m2), suggesting together with
the high-pressure gradient and the low DVI, either a valve obstruction or a PPM. However, cinefluoroscopy (E and F) shows normal closing and
opening angles, confirming the presence of a PPM.
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degree of prosthetic AR, are thus not recommended to quantify
prosthetic AR.20 The ratios of regurgitant jet diameter/LVOT diam-
eter from parasternal long-axis view and jet area/LVOT area from
parasternal short-axis view just below the prosthesis can be used
to estimate the severity of central regurgitation (Figure 11). A ratio
of jet diameter/LVOT diameter .65% suggests severe regurgita-
tion.138 However, using this approach, regurgitation severity may
be overestimated in the case of eccentric or crescent-shaped jets
and underestimated in the case of jets impinging the LVOT wall or
the anterior mitral valve.
For semi-quantitative evaluation of paravalvular AR, careful im-
aging of the neck of the jet in a short-axis view, at the level of the
sewing ring, is required to accurately define its circumferential ex-
tent, which can be expressed as a percentage of the total sewing
ring circumference (,10% ¼ mild; 10–29% ¼ moderate; ≥30%
severe) (Figure 16).14,122,139 This method is however limited by
the eccentric direction and irregular shape of the defects. Rocking
of the prosthesis is usually associated with .40% dehiscence and
thus severe regurgitation.140 The width of the paravalvular jet(s)
at origin in multiple views is also helpful to assess severity.
Due to the shadowing caused by the prosthesis ring or stent, the
vena contracta width (the regurgitant jet as it traverses the aortic
orifice or the effective regurgitant area) may be difficult to measure
correctly in the long-axis view and is inaccurate in case of multiple
jets, irregular orifice shape, or radial extent of paravalvular jets.63
When feasible, the measurement of the vena contracta width is use-
ful to distinguish mild from severe prosthetic AR. Using a Nyquist
limit of 50–60 cm/s, a vena contracta width of ,3 mm correlates
with mild AR, whereas a width .6 mm indicates severe AR.
Quantitative assessments based on the proximal isovelocity sur-
face area (PISA) are generally difficult to apply to mechanical aortic
prostheses.141,142 When assessable, especially in bioprostheses with
central valvular regurgitation, imaging of the flow convergence zone
is usually obtained from the apical three- or five-chamber or para-
sternal long-axis views. The radius of the PISA is measured at dia-
stole using the first aliasing shell.20 R Vol and EROA are obtained
using the standard formulas. An EROA ≥30 mm2 or an R Vol
≥60 mL indicates severe prosthetic AR.
Spectral Doppler parameters are useful to assess prosthetic AR,
because they are less sensitive to the prosthesis position and the as-
sociated shadowing and artefacts. CW Doppler of the AR jet is clas-
sically best obtained from the apical five-chamber view. Effort
should be made to obtain correct Doppler angle to minimize errors
related to possible ultrasound beam misalignment. For eccentric
jets, better signals may be obtained from the right parasternal win-
dow. The PHT of the CW regurgitant jet signal is useful when the
Figure 19 Aortic prosthetic valve obstruction. Haemodynamic profiles of a normally functioning (left panel) vs. obstructed (right panel) pros-
thesis in aortic position. The normally functioning valve shows low transprosthetic peak flow velocity, low-pressure gradients, a large EOA, and a
short acceleration time (time from onset of aortic flow to peak velocity, AT,100 ms), while the obstructed prosthesis shows a high mean pres-
sure gradient, a high peak velocity, a small EOA, and an increased AT (AT.100 ms).
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value is ,200 ms, suggesting severe AR, or .500 ms, consistent
with mild AR. However, intermediate values of PHT (200–
500 ms) are less specific as they are influenced by other variables
such as heart rate, LV compliance and pressures, and the acuteness
of AR (i.e. in acute AR, the PHT is generally short, regardless of the
severity of AR).143,144 For imaging the diastolic flow reversal in the
descending aorta, (i) the sample volume is placed just distal to the
origin of the left subclavian artery; (ii) the pulsed wave Doppler is
aligned along the major axis of the aorta; (iii) the Doppler filter is
decreased to its lowest setting to allow detection of low velocities
(,10 cm/s) and the magnitude of the velocity scale is set to 60–
80 cm/s for more accurate measurement of end-diastolic flow vel-
ocity. With milder degrees of regurgitation, there is a brief reversal
of flow limited to early diastole. As the degree of the regurgitation
increases, the duration and the velocity of the reversal flow during
diastole increase. The presence of holodiastolic flow reversal in the
descending thoracic aorta is indicative of at least moderate AR; severe
AR is suspected when the end-diastolic velocity is .20 cm/s.145 The
main limitation of this parameter is that it is highly influenced by aorta
and LV compliance. Elderly patients with stiff aorta may have holodias-
tolic flow reversal with trivial or mild AR.
Regurgitant volume can be estimated as the difference between
stroke volume at the LVOT (or 2D/3D-derived total LV stroke
volume) and the flow at the mitral annulus or at the RVOT. This
method cannot be used if there is concomitant .mild mitral or pul-
monary regurgitation, respectively. This approach is time consuming
and is associated with several pitfalls, the most important being the
accurate measure of mitral annulus or RVOT diameter. In general, a
regurgitant fraction (RVol divided by the LVOT stroke volume)
.50% indicates severe prosthetic AR.16,20
The impact of prosthetic AR on the LV depends on the chronicity
and severity of the regurgitation as well as on any pre-existing LV
dysfunction. In the absence of other conditions, LV dilatation is sen-
sitive for chronic significant AR while a normal LV size almost ex-
cludes severe chronic AR. Similarly, if LV volumes fail to decrease
after valve replacement for AR or tend to increase after valve re-
placement for AS and in particular if the LV is hyperdynamic, a
haemodynamically significant leak should be suspected. Conversely,
LV dilatation may be absent in acute severe AR.16,20
Integrative assessment
Echocardiographic assessment of prosthetic AR includes integration
of data from 2D/3D imaging of the aortic root, aortic valve, and
ventricle as well as Doppler measures of regurgitation severity
(Table 14). Effort should be made to quantify the degree of regurgi-
tation, except in the presence of mild or less prosthetic AR. The
measurement of the vena contracta width and the calculation of
the EROA, RVol, and regurgitant fraction are recommended,
when feasible. Adjunctive parameters help to consolidate the sever-
ity of AR and should be widely used particularly when there is dis-
cordance between the quantified degree of prosthetic AR and the
clinical context. These parameters should be interpreted according
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Table 13 Grading aortic prosthetic valve obstruction
Normal Possible obstruction Significant obstruction
Qualitative
Valve structure and motion Normal Often abnormala Abnormala
Transvalvular flow envelopeb Triangular, early peaking Triangular to intermediate Rounded, symmetrical
Semi-quantitative
Acceleration time (ms)b ,80 80–100 .100
Acceleration time/LV ejection time ratio ,0.32 0.32–0.37 .0.37
Quantitative
Flow dependent
Peak velocity (m/s)c,d ,3 3–3.9 ≥4
Mean gradient (mmHg)c,d ,20 20–34 ≥35
Increase in mean gradient during stress echo ,10 10–19 ≥20
Increase in mean gradient during follow-up ,10 10–19 ≥20
Flow independent
Effective orifice area (cm2)c,e .1.1 0.8–1.1 ,0.8
Measured EOA vs. normal reference valuec Reference+1SD ,Reference 21SD ,Reference 22SD
Difference (reference EOA2 measured EOA) (cm2)c ,0.25 0.25–0.35 .0.35
Doppler velocity indexc,e ≥0.35 0.25–0.34 ,0.25
See Table 7 to obtain the normal reference values of effective orifice area for the different models and sizes of prostheses.
SD, standard deviation.
aAbnormal mechanical valves: occluder that is immobile or with restricted mobility, thrombus, or pannus; abnormal biologic valves: leaflet thickening/calcification, thrombus, or
pannus.
bThese parameters are affected by LV function and heart rate.
cThe criteria proposed for these parameters are valid for near normal or normal stroke volume (50–90 mL) and flow rate (200–300 mL/s).
dThese parameters are more affected by low or high flow states including low LV output and concomitant aortic regurgitation.
eThis parameter is dependent on the size of the LV outflow tract.
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to the chronicity of prosthetic AR and the LV remodelling. In case of
persistent discrepant results and after elimination of technical er-
rors, or when echocardiography is inconclusive, other imaging mo-
dalities can be used in experienced centres.
Mitral prosthetic valve
Baseline assessment and serial reports
As for aortic PHV, the echocardiographic report should be compre-
hensive (Tables 4 and 10), including the documentation of (i) the
type and size of the prosthetic valve, (ii) blood pressure, (iii) valve
morphology and function (including the measure of closing angle
for bileaflet mechanical valves when possible), (iv) prosthetic pres-
sure gradients and flow velocities (PHT, DVI, EOA), (v) the heart
rate at which gradients are measured, (vi) the presence of regurgi-
tation (location, severity), (vii) LV size and function, (viii) LA size, and
(ix) pulmonary pressure.7,14 Calculated EOA should be compared
with reference values for the prosthetic valve type. The presence
of any PPM should be reported. When needed, the type and reason
for the use of other imaging approaches are to be acknowledged.
Any changes in mitral PHV characteristics are documented.
Imaging assessment
All the components of the mitral PHV should be evaluated (sewing
ring, cusps, occluder(s), surrounding areas). TTE is the first-line im-
aging, while TOE is recommended in case of suspected or con-
firmed dysfunction.15,21,27,29,134 Cinefluoroscopy, cardiac CT, or
Figure 20 Algorithm for evaluation of high transvalvular aortic gradient. Ao, ascending aorta diameter; AT/ET, acceleration time/ejection time
ratio; DVI, Doppler velocity index; EOA, effective orifice area; PPM, patient-prosthesis mismatch. *Bileaflet valves only, small aortic PHV size (19–
21 mm). **Consider underestimation of LVOT diameter and/or LVOT VTI. ***Recalculate EOA using RVOT stroke volume. #If leaflet/disc mo-
tion unclear by TTE, consider cinefluoroscopy or cardiac CT. ##Consider overestimation of LVOT diameter and/or LVOT VTI.
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CMR can be used as complementary tools, if needed (see
above).39,42,64 On TTE, parasternal long- and short-axis views, and
all apical views with multiple angulation and off-axis cuts are needed
to scan the whole sewing ring, the mitral subvalvular apparatus, and
the leaflet/occluder(s) motion. The stents of biological valve are of-
ten well seen in the apical four-chamber view. Colour Doppler im-
aging is used to demonstrate normal forward flow, the expected
washing jets, and when present pathologic regurgitation. Acoustic
shadowing effects may result in inability to adequately image the
LA side of the mitral PHVs, particularly in mechanical prostheses
(Figure 5 Panel A and B).85,86 Visualization can be improved when
the ultrasound beam is oriented parallel to the direction of the oc-
cluder opening. The sub-costal view can be helpful to show para-
prosthetic jets since the effect of shielding is minimized. TOE is
often superior to TTE in detecting and determining the localization
and mechanism of prosthetic MR.146 –148 TOE provides better visu-
alization of the LA and mitral regurgitant jet, but acoustic shadowing
limits visualization of the LV (Figure 5, Panel C and D). The regurgitant
jets are best visualized in the low-oesophageal four-chamber view
with rotation of the probe to two- and three-chamber views to-
gether with anteflexion and retroflexion. If properly aligned in the
centre of the sector, transverse transgastric short-axis view is useful
for imaging the entire circumference of the valve/sewing ring. The
long-axis view (TTE/TOE) is used to measure the LVOT (see
above), while the short-axis view allows determining the circumfer-
ential extent of any paravalvular leak. 3D echocardiography,
especially during TOE, is ideal for imaging the entire mitral pros-
thesis, the whole sewing ring, and the extent of paravalvular regur-
gitation (Figure 21).
Valve morphology and function
Imaging may determine the aetiology of obstruction or regurgitation
by showing evidence of leaflet degeneration (thickening, calcifica-
tion, abnormal mobility) in bioprostheses, a rocking motion of the
sewing ring or abnormal occluder motion in mechanical PHVs.
The occluder in mechanical valves should open quickly and fully
and reduced opening is a reliable sign of obstruction provided
that LV function is good. In normal bileaflet valves, there might be
a slight oscillation of the leaflets during diastole and slight temporal
asymmetry of closure. Mitral valve dehiscence occurs mainly in the
posterior or lateral region and is only very rarely located anteriorly.
The anatomic orientation of the occluders should normally mimic
native valve opening; this preserves the inflow pattern and intraven-
tricular LV vortices that are important for LV filling. This is of par-
ticular importance for single tilting disk prostheses where the
major orifice directs the flow anteriorly as opposed to posteriorly.
In a bioprosthesis, the cusps should be thin and fully mobile, with no
prolapse. As for aortic position, it is normal to see stitches, fibrin
strands, or echoes resembling bubbles in the LV. Heavily calcified
cusps (Figure 22) and reduced occluder motion are the most reliable
signs of obstruction. In a bileaflet mechanical valve, partial obstruc-
tion may be obvious when one leaflet clearly moves less than the
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Table 14 Grading the severity of aortic prosthetic valve regurgitation
Mild Moderate Severe
Qualitative
Valve structure and motion Usually normal Usually abnormala Usually abnormala
Colour flow AR jet widthb Small Intermediate Large (.65% of LVOT diameter)
CW signal of AR jet Incomplete or faint Dense Dense
Diastolic flow reversal in the descending aorta Brief, protodiastolic flow reversal Intermediate Holodiastolic flow reversal
(end-diastolic velocity .20 cm/s)
Semi-quantitative
Pressure half time (ms)c .500 200–500 ,200
Circumferencial extent of paravalvular
regurgitation (%)d
,10 10–29 ≥30
VC width (mm) ,3 3–6 .6
Quantitative
EROA (mm2) ,10 10–29 ≥30
RVol (mL)e ,30 30–59 ≥60
Regurgitant fraction (%) ,30 30–50 .50
+LV sizef
AR, aortic regurgitation; EROA, effective regurgitant orifice; RVol, regurgitant volume; PHT, pressure half time.
aAbnormal mechanical valves: immobile occluder, dehiscence, or rocking (paravalvular regurgitation); abnormal biologic valves: cusps thickening/calcification or prolapse,
dehiscence, or rocking (paravalvular regurgitation).
bParameter applicable to central jets and is less accurate in eccentric jets.
cThis parameter is influenced by left ventricular compliance.
dApplies only to paravalvular regurgitation.
eCan be estimated by the difference of stroke volume in LVOT minus stroke volume in RV outflow tract (if no.mild pulmonary regurgitation) or at the mitral annulus (if no .mild
mitral regurgitation).
fApplies to chronic, late post-operative prosthetic aortic valve regurgitation in the absence of other aetiologies.
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other. If the occluder cannot be imaged, obstruction can be sus-
pected when there is a failure of the colour map to fill (narrow high-
velocity inflow jet wrap-around aliasing) the PHV orifice in all views.
In bioprostheses, the jet can be narrow at the level of the immobile
cusps, but can expand rapidly to fill the orifice towards the tips of
the stents. Severe impairment in LV function may also cause reduced
valve opening, but this will be associated with a thin, low-velocity in-
flow signal on colour imaging.
Acquired mitral PHV obstruction
Doppler assessment
Doppler ultrasound assessment (CW and pulsed wave) of mitral
PHVs is obtained from the apical positions with TTE and low-
oesophageal four-chamber view with TOE. Off-axis views may be
necessary to correctly align the beam parallel to flow.
Mitral inflow peak early diastolic velocity (E velocity) in most nor-
mally functioning bileaflet mechanical PHVs is ,1.9 m/s but can be
as high as 2.4 m/s in small mismatched prostheses.87,149 – 151 The
normal mean transmitral gradient is generally ,5–6 mmHg.152 In-
creasing grades of stenosis are associated with increasing transmitral
velocities and gradients. However, prosthesis size, ventricular and
atrial function, chamber compliances, relative chamber pressures,
and the presence of PPM or of any obstruction can influence trans-
mitral velocities. The presence of tachycardia leads to a shortening
of the diastolic filling and increased in the peak early mitral vel-
ocity.19 Similarly, significant MR, which leads to a volume overload
state, increases transmitral flow velocities. All this highlights the
need for comparing serial values in the same patient over time.14
In the absence of any these conditions, an early mitral peak velocity
≥2.5 m/s and a mean transmitral pressure gradient ≥10 mmHg sug-
gest the presence of severe mitral prosthetic obstruction.14 Signifi-
cant mitral PHV obstruction is usually associated with increased
transprosthetic [mean gradient (≥12 mmHg) during stress echo-
cardiography (Figure 23)].35,135 A change from immediate post-
operative values is also supportive of acquired PHV obstruction.
An increase in mean gradient .5 mmHg with similar heart rates
is suggestive of the occurrence of valve obstruction.
A PHT,130 ms is often consistent with normal mitral PHV func-
tion, whereas a PHT .200 ms on sequential echocardiograms sug-
gests the presence of significant stenosis. As PHT is influenced by
Figure 21 Paravalvular leak due to mitral valve prosthesis dehiscence. Slit-like dehiscence of a bioprosthesis in mitral position from transoe-
sophageal approach, with 3D colour flow Doppler showing the presence of a severe paravalvular regurgitation located posteriorly and involving
.25% of the prosthesis circumference from anterior septum to posterior wall of the left atrium (LA) (B and D). The schematic representation of
the prosthesis orientation as seen from the 3D left atrial perspective in A and C (after reorientation with the aorta up).
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heart rate, LA, and LV compliance, patients with tachycardia or re-
duced atrioventricular compliance may exhibit a normal PHT des-
pite the presence of significant prosthetic valve stenosis. PHT
should not be obtained in case of first-degree atrioventricular block
when E and A velocities are merged or the diastolic filling period is
short. Slight increments in PHT (130–200 ms) are to be interpreted
with caution.149,151
The EOA and the DVI (VTIPrV/VTILVOT) are less flow-dependent
parameters. The EOA is calculated using the continuity equation
(stroke volume/VTIPrV), which is not valid in case of .mild MR or
AR. In case of AR, the RVOT stroke volume can be used as an alterna-
tive approach. Conversely, the PHT-derived EOA is not valid in pros-
thetic mitral valve.103,108 The correct interpretation of DVI requires the
absence of significant AR. Although values are to be referenced against
normal data for each prosthesis type and size, an EOA ,1 cm2 and
a DVI .2.5 raise suspicion for significant mitral PHV obstruction.14
Integrative assessment
Echocardiographic assessment of mitral PHV obstruction includes
integration of data from 2D/3D imaging of the mitral valve as well
as qualitative and quantitative Doppler measures of obstruction se-
verity (Figure 24). Other imaging modalities, when indicated, can be
used to alternatively assess valve motion, structure, and function.
For instance, in case of Doppler silent prosthetic valve thrombosis,
which is characterized by normal or slightly elevated Doppler gradi-
ents, identification of abnormal disk motion of the bileaflet mitral
PHV can require the use of cinefluoroscopy or cardiac CT.45
Interpretation of the data should be performed according to the
date of valve replacement, the prosthesis’ characteristics, and the
haemodynamic conditions. Table 15 lists the imaging parameters
used to assess mitral PHV function. When all parameters are nor-
mal, the probability of valve dysfunction is very low while PHV dys-
function is likely if the majority of them are abnormal.149
Differential diagnosis of high-pressure gradients
In a mitral prosthesis, a mean gradient of 6 mmHg or more may in-
dicate pathologic obstruction, the presence of hyperdynamic states
(e.g. post-op period, anaemia, sepsis), tachycardia, PPM, regurgita-
tion, technical errors, or localized high central jet velocity in bileaflet
mechanical valves.7,14,102,122,136 To overcome the flow dependency
of pressure gradients, a stepwise approach including EOA and DVI
estimation is required (Figure 24). After having excluded possible
technical errors, the EOA is compared with the normal reference
value of EOA for the type and size of prosthesis implanted. If the
EOA is lower than the normal reference value, and especially
when there is a decrease in EOA and DVI during follow-up, the pres-
ence of an abnormal prosthetic motion (or suspected by abnormal
colour flow) in the context of a DVI .2.2 and PHT ≥130 ms
suggests prosthetic valve obstruction. A PHT,130–200 ms in a pa-
tient with a high transprosthetic gradient is not a sign of pathologic
obstruction but rather is a sign of a high transprosthetic flow rate,
especially when the leaflet/disc mobility is normal. In this situation,
lower velocities can be obtained by careful Doppler beam orienta-
tion to avoid this central acceleration. If the EOA is close to the
Figure 22 Degenerative mitral bioprosthesis and high gradient. Dysfunctional bioprosthesis as seen with 2D and 3D transoesophageal echo-
cardiography (TOE). 2D (A) and 3D (B) colour flow imaging of the prosthesis show an abnormal intraprosthetic regurgitation (yellow arrow in 2D
TOE and red arrow in 3D TOE). 2D colour flow imaging of the anterograde flow shows a significant aliasing at the level of the prosthesis indicative
of a high-velocity flow profile (C). Incomplete opening of one of the cusps (anterior) is seen from the 3D dataset (D, white arrow). E and F showing
the anatomic orifice area (AOA) obtained by planimetry and the EOA obtained by the continuity equation. Both confirm significant obstruction.
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reference value, one can calculate the indexed EOA (EOA/BSA)
with measured or projected (normal reference value) EOA. If the
indexed is ≤1.2 cm2/m2, one can assume that PPM is present and
that depending on its degree of severity, it may be partially or totally
responsible for the high gradient. In this context, it is important to
keep in mind that both phenomenon, i.e. PPM and intrinsic dysfunc-
tion, may coexist. Of note, PPM is present early after surgery and on
all subsequent echocardiograms, so further changes in pressure gra-
dients often account for additional intrinsic dysfunction. In the other
case (indexed EOA .1.2 cm2/m2), if the leaflet mobility is consid-
ered to be normal or is undetermined and the DVI is ,2.2, one
should suspect occult mitral trans- or paravalvular regurgitation
or high flow states.
Pathological mitral regurgitation
Colour Doppler evaluation
Rating the severity of prosthetic MR is also a considerable challenge.
The volume of the regurgitant flow jet is determined by the size of
the regurgitant orifice, the driving force from the pressure gradient
across the orifice, and the duration of systole.20
Colour flow imaging is the most common way to assess MR se-
verity. The general assumption is that as the severity of the MR in-
creases, the size and the extent of the jet into the LA also
increase.153 However, the relation between jet area and MR severity
presents a large range of variability. So, this approach is a source of
many errors and is not recommended to assess MR severity.20
Nevertheless, the detection of a large eccentric jet adhering,
swirling, and reaching the posterior wall of the LA is in favour of sig-
nificant prosthetic MR. Conversely, small thin jets that appear just
beyond the mitral leaflets usually indicate mild MR.154
On colour Doppler, paravalvular leaks have a typical appearance
of a jet that passes from the LA into the LA outside the prosthesis
ring and often projects into the atrium in an eccentric direction. For
semi-quantitative evaluation of paravalvular MR, careful imaging of
the neck of the jet in a short-axis view, at the level of the sewing
ring, is required to accurately define its circumferential extent,
which can be expressed as a percentage of the total sewing ring cir-
cumference (,10% ¼ mild; 10–29% ¼ moderate; ≥30% se-
vere).155 Rocking of the prosthesis is usually associated with
.40% dehiscence and thus severe regurgitation.
The vena contracta is the area of the jet as it leaves the regurgitant
orifice; it reflects thus the regurgitant orifice area. The vena contracta
width is useful to distinguish mild from severe prosthetic MR. It is
measure from the parasternal long-axis or apical four-chamber views.
A vena contracta ,3 mm indicates mild prosthetic MR while a width
≥7 mm defines severe MR.151 Due to the shadowing caused by the
prosthetic material, the vena contracta width may be difficult to assess.
It is inaccurate in case of multiple jets or irregular orifice shape.14,20
The PISA method is feasible, especially in bioprosthetic valves
(Figure 13). Imaging of the flow convergence zone is usually obtained
from the apical four-chamber view, though other views can be used
if parallel to regurgitant flow direction.153,156 The area of interest is
optimized by lowering imaging depth and reducing the Nyquist limit
to 15–40 cm/s. The radius of the PISA is measured at mid-systole
Figure 23 Mitral valve prosthesis dysfunction and exercise echocardiography. Significant increase in mean pressure gradient (MPG) during ex-
ercise echocardiography over a prosthetic mechanical valve in mitral position (C) in a patient with mildly elevated resting gradients (A), complaining
of exercise-induced dyspnoea. During exercise (D), there is a significant increase in transtricuspid pressure gradient (TTPG) compared with rest
(B) that parallels the increase in pressure gradients across the mitral prosthesis.
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using the first aliasing. R Vol and EROA are obtained using the stand-
ard formulas. Qualitatively, the presence of flow convergence at a
Nyquist limit of 50–60 cm/s should alert to the presence of severe
MR. Grading of severity of MR classifies regurgitation as mild, mod-
erate, or severe, and sub-classifies the moderate regurgitation group
into ‘mild-to-moderate’ (EROA of 20–29 mm2 or a R Vol of 30–
44 mL) and ‘moderate-to-severe’ (EROA of 30–39 mm2 or a R
Vol of 45–59 mL). Quantitatively, prosthetic MR is considered se-
vere if EROA is ≥40 mm2 and R Vol ≥60 mL. The PISA method
faces several advantages and limitations, which have been addressed
elsewhere. Briefly, the PISA method is based on the assumption of
hemispheric symmetry of the velocity distribution proximal to the
circular regurgitant lesion, which may not hold for eccentric jets,
multiple jets, or complex or elliptical regurgitant orifices.20 Also
the acoustic shadowing may hamper the proper visualization of
the PISA.
Spectral Doppler parameters can be used as additive or alterna-
tive features to corroborate severity of regurgitation. In the absence
Figure 24 Algorithm for evaluation of high transvalvular mitral gradient. DVI, Doppler velocity index; EOA, effective orifice area; PPM, patient-
prosthesis mismatch. *Bileaflet valves only. **Consider underestimation of LVOT diameter and/or LVOT VTI. #If leaflet/disc motion unclear by
TTE, consider cinefluoroscopy or cardiac CT. ##Consider overestimation of LVOT diameter and/or LVOT VTI.
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of prosthetic mitral obstruction, the increase in transprosthetic mi-
tral flow that occurs with increasing MR severity can be detected as
higher flow velocities during early diastolic filling (increased E vel-
ocity). In the absence of mitral stenosis, a peak E velocity .1.5 m/s
at PW Doppler suggests severe prosthetic MR. Conversely, a dom-
inant A wave (atrial contraction) basically excludes severe MR. The
presence of a retrograde systolic flow (PW Doppler 1 cm deep into
the pulmonary vein) in one or more of the pulmonary veins is an-
other specific parameter for significant MR (Figure 13).157 A dense
MR signal with a full CW Doppler envelope also indicates more
severe MR than a faint signal. When truncated (notched) with a
triangular contour and an early peak velocity (blunt), it indicates
elevated LA pressure or a prominent regurgitant pressure wave
in the LA due to severe MR. In eccentric MR, it may be difficult
to record the full CW envelope of the jet because of its
eccentricity.
Regurgitant volume can be calculated by subtracting the forward
stroke volume at the LVOT (or RV stroke volume if .mild AR)
from the total transmitral stroke volume (or 2D/3D-derived total
LV stroke volume). This approach is time consuming and is asso-
ciated with several drawbacks. In general, a regurgitant fraction
.50% indicates severe prosthetic MR.
The impact of prosthetic MR on LV, LA, and pulmonary pressures
depends on the chronicity and severity of the regurgitation as well as
on the pre-existing cardiomyopathy. In the absence of other condi-
tions, LV and LA dilatation are sensitive for chronic significant MR,
while normal size almost excludes severe chronic MR. Similarly, if
LV volumes fail to decrease after valve replacement for MR or
tend to increase after valve replacement for mitral stenosis, and in
particular if the LV is hyperdynamic, a haemodynamically significant
leak should be suspected among other factors. Conversely, LV or
LA dilatation may be absent in acute severe MR.
Given that direct detection of prosthetic MR is often not possible
with TTE, the presence of occult prosthetic MR should be sus-
pected when the following signs are present: (i) the presence of
flow convergence on the LV side of the prosthesis during systole;
(ii) the presence of a turbulent colour flow within the LA distal to
the acoustic shadow; (iii) increased mitral peak E wave velocity, gra-
dient, and/or DVI; (iv) unexplained or new worsening of pulmonary
arterial hypertension; and a dilated and hyperkinetic LV. PHT is of-
ten normal in prosthetic MR unless there is concomitant sten-
osis.149,158 TOE should be systematically performed when there is
a clinical or TTE suspicion of occult MR.134
Integrative assessment
Echocardiographic assessment of prosthetic MR includes integra-
tion of data from 2D/3D imaging of the valve and ventricle as well
as Doppler measures of regurgitation severity (Table 16). An effort
should be made to quantify the degree of regurgitation, except in
the presence of mild or less prosthetic MR. The measurement of
the vena contracta width and the calculation of the EROA, RVol,
and regurgitant fraction is recommended, when feasible. Adjunctive
parameters help to consolidate the severity of MR and should be
widely used particularly when there is discordance between the
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Table 15 Grading mitral prosthetic valve obstruction
Normal Possible obstruction Significant obstruction
Qualitative
Valve structure and motion Normal Often abnormala Abnormala
Semi-quantitative
Pressure half time (ms)b ,130 130–200 .200
Quantitative
Flow dependent
Peak velocity (m/s)c,d,f ,1.9 1.9–2.5 ≥2.5
Mean gradient (mmHg)c,d,f ≤5 6–10 ≥10
Increase in mean gradient during stress echo ,5 5–12 .12
Follow-up increase in mean gradient ,3 3–5 .5
Flow independent
Effective orifice area (cm2)c,g ≥2 1–2 ,1
Effective orifice area vs. normal reference valuec,g Reference+1SD ,Reference 21SD ,Reference 22SD
Difference (reference EOA2 measured EOA) (cm2)c ,0.25 0.25–0.35 .0.35
Doppler velocity indexc,d,e,g ,2.2 2.2–2.5 .2.5
See Table 8 to obtain the normal reference values of effective orifice area for the different models and sizes of prostheses.
PHT, pressure half time; SD, standard deviation.
aAbnormal mechanical valves: occluder that is immobile or with restricted mobility, thrombus or pannus; abnormal biologic valves: cusps thickening/calcification, thrombus, or
pannus.
bThis parameter is influenced by heart rate, left atrial compliance, and left ventricular compliance. This parameter should not be measured during tachycardia, first atrioventricular
block, or circumstances that cause fusion between the E and A velocities or shorten the diastolic filling period.
cThe criteria proposed for these parameters are valid for near normal or normal diastolic volume (i.e. stroke volume: 50–90 mL) and heart rate (50–80 bpm).
dThese parameters are also abnormal in the presence of significant mitral prosthesis regurgitation.
eThis parameter is dependent on the size of the LV outflow tract. In atrial fibrillation, the VTIPrMV and the VTILVOT should be measured in matched cardiac cycles.
fThese parameters are more affected by flow and heart rate.
gThese parameters are not valid when .mild concomitant aortic or mitral regurgitation is present.
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quantified degree of prosthetic MR and the clinical context. These
parameters should be interpreted according to the chronicity of
prosthetic MR and the LV remodelling. If results are still discrepant
and after elimination of technical errors, or when echocardiography
is inconclusive, other imaging modalities can be used in experienced
centres to assess valve motion, structure, and function.
Tricuspid prosthetic valve
Baseline assessment and serial reports
The echocardiographic report includes the documentation of (i) the
type and size of the prosthetic valve, (ii) blood pressure, (iii) valve
morphology and function, (iv) prosthetic pressure gradients
and flow velocities (EOA, DVI), (v) the heart rate at which gradients
are measured, (vi) the presence of regurgitation (location, severity),
(vii) RV size and function, (viii) RA size, (ix) inferior vena cava
dimensions and respiratory changes, and (x) pulmonary pressure
(Tables 4 and 10).7,14 Calculated EOA should be compared with ref-
erence values for the prosthetic valve type. When needed, the type
and reason for the use of other imaging approaches are to be ac-
knowledged. Any changes in tricuspid PHV characteristics are
documented.
Imaging assessment
Because of the anterior position of the tricuspid PHV, assessment of
tricuspid valve by TTE is generally superior to imaging by TOE.81
The three main TTE views allowing the tricuspid valve visualization
are the parasternal (long-axis view of RV inflow, short-axis view at
the level of the aortic valve), the apical four-chamber, and the sub-
costal views. All views, particularly from the apex, will need multiple
tilting to obtain optimal views of the RV and tricuspid valve. The RV
inflow and sub-costal views are very useful for assessing colour flow
through tricuspid prosthesis, because the acoustic shadowing inter-
ference is less than in apical views.14,20 With TOE standard views of
the tricuspid prosthesis include mid-oesophageal four-chamber and
modified bicaval views, the mid-oesophageal inflow–outflow view,
and the transgastric RV inflow–outflow view.
Valve morphology and function
Imaging may identify the aetiology of PHV dysfunction including
obstruction or regurgitation due to bioprosthesis degeneration
(thickening, calcification, abnormal mobility), rocking motion of
the sewing ring, or abnormal occluder motion in mechanical
PHVs.
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Table 16 Imaging criteria for grading the severity of prosthetic mitral valve regurgitation
Mild Moderate Severe
Qualitative
Valve structure and motion Usually normal Usually abnormala Usually abnormala
Colour flow MR jetb Small Intermediate Large central jet or eccentric jet adhering,
swirling, and reaching the posterior LA wall
Flow convergencec No or small Intermediate Larged
CW signal of MR jet Faint/Parabolic Dense/Parabolic Dense/triangular
Semi-quantitative
Pulmonary vein flow Systolic dominance Systolic bluntinge Systolic flow reversalf
Mitral inflow Variable Variable Peak velocity ≥1.9 m/s; Mean gradient ≥5 mmHg
Doppler velocity index (VTIPrMV/VTILVOT) ,2.2 2.2–2.5 .2.5
VC width (mm) ,3 3–5.9 ≥6




EROA (mm2) ,20 20–39 ≥40
RVol (mL)i ,30 30–59 ≥60
Regurgitant fraction (%) ,30 30–50 .50
+LV and LA sizej and the systolic pulmonary
arterial pressure
aAbnormal mechanical valves: immobile occluder, dehiscence, or rocking (paravalvular regurgitation); abnormal biologic valves: cusps thickening/calcification, dehiscence, or
rocking (paravalvular regurgitation).
bParameter applicable to central jets and is less accurate in eccentric jets.
cAt a Nyquist limit of 50–60 cm/s.
dPISA radius ,0.4 and ≥0.9 cm for central jets, respectively, with a baseline shift at a Nyquist limit of 40 cm/s.
eUnless other reasons of systolic blunting (atrial fibrillation, elevated LA pressure).
fPulmonary venous systolic flow reversal is specific but not sensitive for severe MR.
gApplies only to paravalvular regurgitation.
hThese quantitative parameters are less well validated than in native MR.
iCan be estimated by the PISA method if feasible or by calculating the difference between stroke volume measured at the mitral annulus and stroke volume measured in the LVOT
(if no .mild aortic regurgitation).
jApplies to chronic, late post-operative prosthetic mitral valve regurgitation in the absence of other aetiologies and acute MR.
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Acquired tricuspid PHV obstruction
Doppler assessment
Doppler ultrasound assessment (CW and pulsed wave) of tricuspid
PHVs is obtained from multiple views. Various transducer positions
and off-axis views are used to correctly align the ultrasound beam as
much as parallel to flow. Determination of the severity of tricuspid
PHV stenosis has been validated in a limited number of patients.
Tricuspid inflow peak early diastolic velocity (E velocity) in most
normally functioning tricuspid PHVs is ,1.9 to 2 m/s.159,160 The
normal mean transtricuspid gradient is often ,6 to 9 mmHg, de-
pending on the prosthesis type. Increasing grades of obstruction
are associated with increasing transmitral velocities and gradients.
However, velocities vary with respiration, heart rate, chamber com-
pliances and pressures, and the presence of any obstruction. To
minimize the respiratory flow variations, averaging a minimum of
5 cycles (during end-expiratory or quiet respiration) is recom-
mended whether the patient is in sinus rhythm or in atrial fibrillation.
In the absence of tachycardia or significant TR, an early tricuspid
peak velocity ≥1.9–2 m/s and a mean transtricuspid pressure gradi-
ent ≥6–9 mmHg are suggestive of possible tricuspid prosthetic ob-
struction.161 – 163
A short PHT is often consistent with normal tricuspid PHV func-
tion, whereas a significantly prolonged PHT on sequential echocar-
diograms suggests possible stenosis. As this parameter is influenced
by heart rate and right chambers compliance, PHT should be inter-
preted with caution.161,162
The EOA and the DVI (VTIPrV/VTILVOT) are less flow-dependent
parameters. The DVI can be used to distinguish stenosis from regur-
gitation, because in both cases the gradient is increased. A DVI ≥3.2
for tricuspid biosprosthetic valves or ≥2 for mechanical bileaflet
valve in the absence of significant AR suggests possible tricuspid
stenosis.81,163 The EOA derived by PHT has not been validated in
tricuspid PHV. The EOA is thus calculated using the continuity equa-
tion (stroke volume/VTIPrV), which is not valid in case of .mild AR.
In case of AR, the RVOT can be used as an alternative approach.
Of note, no cut-off value of EOA has been validated.
Integrative assessment
Echocardiographic assessment of tricuspid PHV obstruction in-
cludes integration of data from 2D/3D imaging of the tricuspid valve
as well as Doppler measures of stenosis severity (Figure 25). Other
imaging modalities, when indicated, can be used to alternatively as-
sess valve motion, structure, and function. Interpretation of the data
should be performed according to the date of valve replacement,
the prosthesis’ characteristics, and the haemodynamic conditions.
Table 17 lists the imaging parameters used to assess tricuspid PHV
function. More parameters are abnormal, the higher the likelihood
of possible PHV dysfunction.
Figure 25 Echocardiographic evaluation of bioprostheses in tricuspid position. Normally functioning prosthesis in A–F. Dysfunctional pros-
thesis with signs of severe stenosis in G and H. The white arrows in A–C indicate the pillars of the prosthesis’s frame as seen in 2D transthoracic
echocardiography (A) and 3D transoesophageal echocardiography (B, closed position; C, opened position). The haemodynamic parameters [peak
early diastolic velocity, pressure half time (PHT), Doppler velocity index (DVI), and mean pressure gradient (MPG)] are all normal (E and F). Patho-
logic increased echogenicity of the bioprosthesis (red arrow, G), suggestive of prosthesis dysfunction and abnormal haemodynamic parameters,
confirming prosthesis dysfunction (H ).
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Differential diagnosis of high-pressure gradients
In a tricuspid prosthesis, a mean gradient of .6 mmHg may denote
pathologic obstruction, the presence of hyperdynamic states (e.g.,
post-op period, anaemia, sepsis), tachycardia, PPM, regurgitation,
technical errors, or localized high central jet velocity (only for bileaf-
let mechanical valves).122,124 In the presence of normal leaflet/disc
mobility, normal or mildly prolonged PHT, and normal DVI, one
should suspect PPM, localized high gradient in bileaflet mechanical
valves (redo the Doppler recording avoiding central jet velocities),
PHV regurgitation or high flow states. Conversely, the presence of
an abnormal PHV motion in the context of a high DVI, prolonged
PHT, and progressive increase in mean gradient during follow-up
suggests prosthetic valve obstruction.
Pathological tricuspid regurgitation
Colour Doppler evaluation
Grading the severity of prosthetic TR is in principle similar to pros-
thetic MR. However, because standards for determining the TR se-
verity are less robust than for MR, the algorithms for relating colour
flow-derived parameters to TR severity are less well developed.
Colour flow imaging is useful for screening the presence of TR.
The general assumption is that larger colour jets that extend deep
into the RA represent more TR than smaller thin jets that are
seen just beyond the tricuspid valve. As for MR, this method is a
source of many errors and is limited by several technical and haemo-
dynamic factors.163,164 Colour flow imaging is not recommended for
assessing TR severity. Nevertheless, the detection of a large eccen-
tric jet adhering, swirling, and reaching the posterior wall of the RA
is in favour of severe TR.14,20 Conversely, small thin central jets usu-
ally indicate mild TR. It should be noted that normal bioprosthetic
valve might have mild TR in the early post-operative period.
The vena contracta width of the TR is typically imaged in the ap-
ical four-chamber view using the same settings as for MR. Averaging
measurements over at least two to three beats are recommended.
A vena contracta ≥7 mm is in favour of severe while a diameter
,6 mm may be either mild or moderate TR.165 Due to the shadow-
ing caused by the prosthetic material, the vena contracta width may
be difficult to assess. It is inaccurate in case of multiple jets or irregu-
lar orifice shape.
Although providing quantitative assessment, the PISA method has
not been validated in the setting of tricuspid PHV. However, in the
absence of distortion of the flow convergence zone, the PISA meth-
od can be applied to grade severe prosthetic TR.14,20
Spectral Doppler parameters can be used as additive or alterna-
tive features to corroborate severity of regurgitation. Similar to MR,
the severity of TR will affect the early tricuspid diastolic filling (E vel-
ocity). In the absence of tricuspid stenosis, an elevated tricuspid
peak E velocity (1.9–2.1 cm/s or greater), although not specific, is
a common finding in severe TR. The presence of a holosystolic re-
versal flow (PW Doppler) in the hepatic vein is another specific par-
ameter for significant TR.164,166 A dense TR signal with a full CW
Doppler envelope also indicates more severe TR than a faint signal.
When truncated (notched) with a triangular contour and an early
peak velocity (blunt), it indicates a prominent regurgitant pressure
wave in the RA due to severe TR. In eccentric TR, it may be difficult
to record the full CW envelope of the jet.
Quantitative PW Doppler method has not been validated to
quantify the prosthetic TR severity.
The impact of prosthetic TR on right heart chambers depends on
the chronicity and severity of the regurgitation as well as on the pre-
existing conditions. In the absence of other conditions, RV and RA
enlargement (with diastolic septal flattening) and inferior vena cava
dilatation with minimal change on respiration are sensitive for
chronic significant TR while normal size almost excludes severe
chronic TR. When these findings are absent, the presence of signifi-
cant TR should be questioned.
Integrative assessment
Echocardiographic assessment of prosthetic TR includes integration
of data from 2D/3D imaging of the valve, right heart chambers, sep-
tal motion and inferior vena cava, as well as Doppler measures of
regurgitant severity (Table 18). The consensus of the experts is to
advocate grading the severity of TR by using the vena contracta
width, except in the presence of mild or trivial TR. Adjunctive para-
meters help to consolidate about the severity of TR. These para-
meters should be interpreted according to the chronicity of
prosthetic TR and the RV remodelling. In case of discrepant/incon-
clusive echo results, other imaging modalities imaging can be used in
experienced centres to assess valve motion, structure, and function.
Pulmonary prosthetic valve
Baseline assessment and serial reports
The echocardiographic report includes the documentation of (i) the
type and size of the prosthetic valve, (ii) valve morphology and func-
tion, (iii) prosthetic pressure gradients and flow velocities, (iv) the
presence of regurgitation (location, severity), (v) RV size and func-
tion, (vi) pulmonary pressure, (vii) pulmonary artery dimension
(Tables 4 and 10).7,14 When needed, the type and reason for the
use of other imaging approaches are to be acknowledged. Any
changes in pulmonic PHV characteristics are reported.
Imaging assessment
Because the pulmonary valve is located anteriorly and superiorly, it
is often difficult to fully visualize by either TTE or TOE.20 With TTE,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .




Valve structure and motion Normal Often abnormalb
Semi-quantitative
Pressure half time (ms) ,130 ≥130
Doppler velocity index ,2 ≥2
Quantitative
Flow dependent
Peak velocity (m/s)c ,1.9 ≥1.9
Mean gradient (mmHg)c ,6 ≥6
aBecause of respiratory variation, average 3–5 cycles in sinus rhythm.
bCusps thickening or immobility.
cMay be increased also with valvular regurgitation.
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Table 18 Grading the severity of tricuspid prosthetic valve regurgitation
Mild Moderate Severe
Qualitative
Valve structure and motion Usually normal Usually abnormala Usually abnormala
Colour flow TR jetb Small Intermediate Very large central jet or eccentric wall impinging jet
Flow convergencec No or small Intermediate Larged
CW signal of TR jet Faint/Parabolic Dense/Parabolic Dense/Early peaking
Semi-quantitative
Hepatic vein flow Systolic dominance Systolic bluntinge Systolic flow reversalf
Tricuspid inflow Variable Variable Elevated pressure gradient
VC width (mm) ND ,7 .7
Quantitative
EROA (mm2) ND ND ND
R Vol (mL) ND ND ND
Regurgitant fraction (%) ND ND ND
+RA-RV-IVC dimensionsg
aDehiscence (paravalvular regurgitation), leaflet thickening/calcification (paravalvular regurgitation); abnormal biologic valves: cusps thickening/calcification.
bParameter applicable to central jets and is less accurate in eccentric jets.
cAt a Nyquist limit of 50–60 cm/s.
dBaseline Nyquist limit shift of 28 cm/s.
eUnless other reasons of systolic blunting (atrial fibrillation, elevated RA pressure).
fPulmonary venous systolic flow reversal is specific but not sensitive for severe MR.
gApplies to chronic, late post-operative prosthetic tricuspid valve regurgitation.
Figure 26 Degenerative bioprosthesis in pulmonary position. Highly turbulent anterograde flow related both to the presence of stenosis and
significant prosthesis regurgitation (A). The anterograde flow velocity and mean pressure gradient (MPG) are increased (B). An intense continuous
wave Doppler signal and a short PHT are seen, related to the presence of a concomitant intraprosthetic regurgitation (D). The transtricuspid
systolic gradient is measured in C.
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the pulmonic valve is imaged from the parasternal short-axis view at
the level of the aortic valve, the RVOT view, and the sub-costal view.
Tilting the probe in a slight cranial direction gives a clearer view of
both the pulmonic valve and the proximal pulmonary artery. On
TOE, the pulmonic valve is imaged from the high oesophageal
view at 508–908 near the level of the short-axis view of the aortic
valve (usually found at 308). Slight withdrawal of the probe from
the level of the aortic valve at 508–908may facilitate visualization of
the pulmonic valve, main pulmonary artery, and its bifurcation. It can
also be imaged from a deep transgastric view in a 1208 imaging plane.
Colour flow Doppler is used to detect any flow acceleration or re-
gurgitation. 3D TOE allows for accurate evaluation of bioprosthetic
pulmonary valve structure and function, and enhances the precision
and monitoring of percutaneous valvuloplasty.167
Valve morphology and function
Pulmonic PHV dysfunction, stenosis and/or regurgitation, is generally
associated with abnormal valve morphology (calcifications, pannus,
thrombus) and/or mobility (rocking motion of the sewing ring,
abnormal occluder motion).
Acquired pulmonary PHV obstruction
Doppler assessment
Using both CW and PW Doppler at the level of the pulmonary
valve, velocities across the pulmonary valve are measured. Several
cycles should be recorded to account for small variations in veloci-
ties during the respiratory cycle. The funnel shape of the RVOT and
the potential concomitant stenosis of the pulmonary branches limit
the accuracy of the continuity equation to calculate the EOA. Cur-
rently, pulmonary valve conduits are commonly used, and it is im-
portant to know the type of degeneration that these devices may
show (edge stenosis), which may cause increased gradients.14,22
Current evidence on the determination of the prosthetic pul-
monary obstruction is limited. Doppler findings suspicious of pros-
thetic pulmonary valve stenosis include: narrowing of forward
colour flow map, single transvalvular peak velocity .3.2 m/s for
bioprostheses (mean gradient ≥20 mmHg) or .2.5 m/s for
homografts (mean gradient ≥15 mmHg), increase in peak velocity
on serial studies, elevated RV systolic pressure, and new impairment
of RV function (Figure 26). When stenosis of the pulmonary
branches co-exists, PW Doppler may be preferred over CW Dop-
pler to measure the transprosthetic gradient (provided that there is
not aliasing).168,169
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aCusps thickening or immobility.
bThe criterion is valid for near normal or normal stroke volume (50–90 mL) and
flow rate (200–300 mL/s).
cIncrease in peak velocity on serial studies is the more reliable parameter.
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Table 20 Grading the severity of pulmonary prosthetic valve regurgitation
Mild Moderate Severe
Qualitative
Valve structure and motion Usually normal Usually abnormala Usually abnormala
Colour flow PR jet widthb,c Small Intermediate Large (.50–65% of RVOT diameter)
CW signal of PR jet Incomplete or faint Dense Dense
CW Jet deceleration rate Slow Variable Steep, early termination of diastolic flowd
Diastolic flow reversal in the pulmonary artery None Present Present
Pulmonary vs. Systemic flow by PW Doppler Slightly increased Intermediate Greatly increased
Semi-quantitative
Pressure half time (ms)e ND ND ,100 ms
Quantitative ND ND ND
+RV sizef
aAbnormal mechanical valves: immobile occluder, dehiscence, or rocking (paravalvular regurgitation); abnormal biologic valves: leaflet thickening/calcification or prolapse,
dehiscence, or rocking (paravalvular regurgitation).
bParameter applicable to central jets and is less accurate in eccentric jets.
cAt a Nyquist limit of 50–60 cm/s; parameter applies to central jets and not eccentric jets.
dSteep deceleration is not specific for severe PR.
ePressure half time is shortened with increasing RV diastolic pressure.
fApplies to chronic, unless other cause of RV dilatation exists, including residual postsurgical dilatation.
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Echocardiographic assessment of pulmonary PHV obstruction in-
cludes integration of data from 2D/3D imaging of the pulmonic valve
as well as Doppler measures of stenosis severity. Other imaging mo-
dalities, when indicated, can be used to alternatively assess valve
structure, motion, and function. Table 19 lists the imaging para-
meters used to assess pulmonary PHV function.
Pathological pulmonary regurgitation
Colour Doppler evaluation
There is a paucity of data regarding the imaging assessment of pros-
thetic pulmonary regurgitation (PR). Detection of prosthetic PR re-
lies almost exclusively on colour flow imaging. PR is diagnosed by
documenting a diastolic jet in the RVOT directed towards the RV.
Significant prosthetic PR is distinguished from mild PR by a longer
duration of flow (holodiastolic) and a wider jet as the regurgitant jet
crosses the pulmonic valve.170 However, in severe PR, where equal-
ization of diastolic pulmonary artery and RV pressures occurs earlier
in diastole, the colour jet area can be brief and inaccurate (depend-
ency on the driving pressure).171 The assessment of prosthetic PR
severity is usually estimated by the diameter of the jet at its ori-
gin.172 –174 The maximum colour jet diameter (width) is measured
in diastole immediately below the pulmonic valve (at the junction
of the RVOT and pulmonary annulus) in the parasternal short-axis
view or from the sub-costal view. Although this measurement suf-
fers from a high inter-observer variability, a jet width that occupies
.50–65% of the RV outflow tract width measured in the same
frame suggests severe PR.
Detection of reversal colour Doppler flow in pulmonary arteries
is a specific sign of at least moderate to severe PR.14,20
Although the vena contracta width is probably a more accurate
method than the jet width to evaluate PR severity by colour Dop-
pler, it lacks validation studies. In some patients, the flow conver-
gence zone can be assessed. However, no studies have examined
the clinical accuracy of this method in quantifying the severity of PR.
A short PHT (,100 ms) (sine wave shape of the CW Doppler
signal due to rapid deceleration rate with termination of flow in
mid to late diastole) and a dense CW PR jet are not specific but
compatible with severe prosthetic PR.175,176 The PHT is dependant
not only on PR severity but also on diastolic intrapulmonary pres-
sures and on diastolic properties of the RV, with shorter PHT
when RV physiology is restrictive.
Theoretically, PW Doppler assessment of the forward and re-
verse flows at the pulmonary annulus and in the pulmonary artery
can been used to calculate R Vol and regurgitant fraction. The pul-
monary annulus should be measured carefully during early ejection
(2–3 frames after the R wave on the ECG), just below the valve. This
technique is subject to errors in measurement and is not validated
for this purpose. A regurgitant fraction ,30% is suggestive of mild
PR, whereas a regurgitant fraction .50% can be consistent with
severe PR.174
Evidence of RV dilatation with flattening of the interventricular
septum in diastole and resultant paradoxical motion is suggestive
but not specific for severe PR. Nevertheless, its absence suggests
milder degree of PR or acute PR. Of note, dilatation can be observed
in other conditions (non-specific) or may be absent in acute
severe PR.
Integrative assessment
Echocardiographic assessment of prosthetic PR includes integration
of data from 2D/3D imaging of the pulmonary valve and RV as well
as Doppler measures of regurgitation severity (Table 20). As for all
regurgitant lesions, all modalities should be used. In case of discrep-
ant/ inconclusive echo results, CMR can be used in experienced
centres.
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